0001104659-17-032338.txt : 20170512 0001104659-17-032338.hdr.sgml : 20170512 20170512170308 ACCESSION NUMBER: 0001104659-17-032338 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 41 CONFORMED PERIOD OF REPORT: 20170331 FILED AS OF DATE: 20170512 DATE AS OF CHANGE: 20170512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avista Healthcare Public Acquisition Corp. CENTRAL INDEX KEY: 0001661181 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37906 FILM NUMBER: 17839693 BUSINESS ADDRESS: STREET 1: 65 EAST 55TH STREET STREET 2: 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212 593-6900 MAIL ADDRESS: STREET 1: 65 EAST 55TH STREET STREET 2: 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 10-Q 1 a17-8939_110q.htm 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2017

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-37906

Avista Healthcare Public Acquisition Corp.

(Exact Name of Registrant as Specified in its Charter)

Cayman Islands		98-1329150
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

65 East 55th Street, 18th Floor New York, NY		10022
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (212) 593-6900

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	o	Accelerated filer	o
Non-accelerated filer	x(Do not check if a smaller reporting company)
		Smaller reporting company	o
		Emerging growth company	x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes x No o

At May 9, 2017, there were 31,000,000 Class A ordinary shares, $0.0001 par value per share and 7,750,000 Class B ordinary shares, $0.0001 par value per share outstanding.

Table of Contents

Table of Contents

		Page
PART I.	FINANCIAL INFORMATION	3
Item 1.	Financial Statements	3
	Condensed Balance Sheets	3
	Condensed Statements of Operations (unaudited)	4
	Condensed Statements of Cash Flows (unaudited)	5
	Notes to Condensed Financial Statements (unaudited)	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	12
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	16
Item 4.	Controls and Procedures	16
PART II.	OTHER INFORMATION	17
Item 1.	Legal Proceedings	17
Item 1A.	Risk Factors	17
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	17
Item 3.	Defaults Upon Senior Securities	18
Item 4.	Mine Safety Disclosures	18
Item 5.	Other Information	18
Item 6.	Exhibits	18
	Signatures	19
	Exhibit Index	20

Table of Contents

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

Avista Healthcare Public Acquisition Corp.

CONDENSED BALANCE SHEETS

	As of			As of
	March 31, 2017			December 31, 2016
	(Unaudited)
ASSETS
Current assets
Cash	$	486,200		$	1,040,068
Prepaid expenses	393,526			395,843
Total current assets	879,726			1,435,911

Accrued interest receivable held in trust account	359,511			—
Cash and cash equivalents held in trust account	310,000,000			310,000,000
Total assets	$	311,239,237		$	311,435,911

LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities
Offering costs payable	$	—		$	427,578
Accrued expenses	140,823			50,782
Total current liabilities	140,823			478,360

Deferred underwriting commission	10,850,000			10,850,000

Total liabilities	10,990,823			11,328,360

COMMITMENTS
Class A ordinary shares subject to possible redemption, $0.0001 par value; 29,490,640 and 29,510,755 shares at conversion value at March 31, 2017 and December 31, 2016	295,248,410			295,107,550
Shareholders’ equity
Preferred shares, $0.0001 par value, 1,000,000 shares authorized: no shares issued and outstanding at March 31, 2017 and December 31, 2016	—			—
Ordinary shares, $0.0001 par value, 220,000,000 shares authorized
Class A ordinary shares 200,000,000 shares authorized; 1,509,360 and 1,489,245 shares issued and outstanding at March 31, 2017 and December 31, 2016 respectively, (excluding 29,490,640 shares subject to possible redemption at March 31, 2017)	151			149
Class B ordinary shares, 20,000,000 shares authorized; 7,750,000 and 7,750,000 shares issued and outstanding at March, 31, 2017 and December 31, 2016	775			775
Additional paid-in capital	5,092,075			5,232,937
Accumulated deficit	(92,997		)	(233,860		)
Total shareholders’ equity	5,000,004			5,000,001
Total liabilities and shareholders’ equity	$	311,239,237		$	311,435,911

The accompanying notes are an integral part of the unaudited condensed financial statements.

Table of Contents

Avista Healthcare Public Acquisition Corp.

CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)

	For the Three			For the Three
	Months Ended			Months Ended
	March 31, 2017			March 31, 2016

Operating costs	$	(218,648	)	$	(15,550	)
Loss from operations	(218,648		)	(15,550		)
Other income:
Interest income	359,511			—
Net income/(loss)	$	140,863		$	(15,550	)

Weighted average number of shares outstanding, basic and diluted	9,239,245			7,500,000
Basic and diluted net income/(loss) per share	$	0.02		$	(0.00	)

The accompanying notes are an integral part of the unaudited condensed financial statements.

Table of Contents

Avista Healthcare Public Acquisition Corp.

CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)

	For the Three				For the Three
	Months Ended				Months Ended
	March 31, 2017				March 31, 2016

Cash flows from operating activities:
Net income/(loss)	$	140,863			$	(15,550		)
Adjustments to reconcile net income to net cash used in operating activities:
Change in operating assets and liabilities:
Accrued interest receivable held in trust account	(359,511			)	—
Accounts receivable	—				(241			)
Prepaid expenses	2,317				—
Accrued expenses	90,041				15,550
Net cash used in operating activities:	(126,290			)	(241			)

Cash flows from financing activities:
Payment of offering costs	(427,578			)	(20,000			)
Net cash used in financing activities:	(427,578			)	(20,000			)
Net decrease in cash	(553,868			)	(20,241			)
Cash at beginning of period	1,040,068				126,062
Cash at end of period	$	486,200			$	105,821
Supplemental disclosure of non-cash financing activities:
Change in ordinary shares subject to possible redemption	$		140,860		$		—

The accompanying notes are an integral part of the unaudited condensed financial statements.

Table of Contents

AVISTA HEALTHCARE PUBLIC ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

Note 1—Organization and Plan of Business Operations

Organization and General

Avista Healthcare Public Acquisition Corp. (the “Company”) was incorporated as a Cayman Islands exempted company on December 4, 2015. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). The Company intends to focus its search for a target business in the healthcare industry, although it may seek to complete a Business Combination with an operating company in any industry or sector. The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (as amended, the “JOBS Act”). The Company’s sponsor is Avista Acquisition Corp. (the “Sponsor”), which was incorporated on December 4, 2015.

At March 31, 2017, the Company had not commenced any operations. All activity through March 31, 2017 relates to the Company’s formation, its initial public offering of 30,000,000 units (the “Units”) at $10.00 per Unit, each consisting of one of the Company’s Class A ordinary shares, par value $0.0001 per share (the “Class A Shares”), and one warrant (the “Warrants”) to purchase one-half of one Class A Share (the “Public Offering”) and efforts directed towards locating a suitable initial Business Combination. The Company also granted the Underwriters (as defined below) of the Public Offering a 45-day option to purchase up to 4,500,000 additional Units to cover over-allotments (the “Over-allotment Option”). The Class A Shares sold as part of the Units in the Public Offering are sometimes referred to herein as the “public shares.” The Company will not generate any operating revenues until after completion of a Business Combination, at the earliest. The Company has selected December 31 as its fiscal year end.

Financing

The registration statement for the Company’s Public Offering was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on October 7, 2016. The Public Offering closed on October 14, 2016 (the “Close Date”). The Sponsor and certain other accredited investors (the “Initial Shareholders”) purchased an aggregate of 16,000,000 warrants (the “Private Placement Warrants”) at a purchase price of $0.50 per warrant, or $8,000,000 in the aggregate, in a private placement at the Close Date (the “Private Placement”).

On November 28, 2016, the Company consummated the closing of the sale of 1,000,000 Units which were sold pursuant to the Over-allotment Option. The Company also consummated a simultaneous private placement of an additional 400,000 Private Placement Warrants with the Initial Shareholders. Following the closing of the Over-allotment Option and Private Placement, an additional $10,000,000 was placed into the Trust Account, after paying additional underwriting discounts of $200,000.

The Company intends to finance a Business Combination with net proceeds from its $310,000,000 Public Offering and $8,200,000 Private Placement (see Note 3). Following the Public Offering, after paying underwriting discounts of $6,200,000 and funds designated for operational use of $2,000,000, the remaining net proceeds of $310,000,000 were deposited in a trust account with Continental Stock Transfer and Trust Company acting as trustee (the “Trust Account”) as described below.

The Trust Account

On January 6, 2017, the funds in the Trust Account were invested in U.S. government treasury bills, which matured on April 6, 2017. On April 6, 2017, the funds in the Trust Account were reinvested in US government treasury bills, maturing on July 6, 2017, until the earlier of (i) the consummation of the Business Combination and (ii) the Company’s failure to consummate a Business Combination within the prescribed time. Placing funds in the Trust Account may not protect those funds from third-party claims against the Company. Although the Company will seek to have all vendors, service providers (other than its independent auditors), prospective target businesses or other entities it engages execute agreements with the Company waiving any claim of any kind in or to any monies held in the Trust Account, there is no guarantee that such persons will execute such agreements. The Sponsor has agreed that it will be liable to the Company under certain circumstances if and to the extent any claims by such persons reduce the amount of funds in the Trust Account below a specified threshold. The Company has not independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believes that the Sponsor’s only assets are securities of the Company.

Table of Contents

Therefore, the Sponsor may not be able to satisfy those obligations should they arise. The remaining net proceeds (not held in the Trust Account) may be used to pay for business, legal and accounting due diligence on prospective acquisitions and continuing general and administrative expenses as well as any taxes. The balance in the Trust Account as of March 31, 2017 was $310,359,511, of this amount $359,511 was accrued interest.

Business Combination

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering, the sale of the Private Placement Warrants and the Over-allotment Option, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide the holders of the public shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their public shares upon the completion of the Business Combination, either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer, in either case at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the Business Combination, including interest (which interest shall be net of taxes payable) divided by the number of then outstanding public shares. Notwithstanding the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the public shares. In connection with any shareholder vote required to approve any Business Combination, the Initial Shareholders have agreed (i) to vote any of their respective Ordinary Shares (as defined below) in favor of the Business Combination and (ii) not to redeem any of their Ordinary Shares in connection therewith.

The NASDAQ rules require that the Business Combination must be with one or more target businesses that together have an aggregate fair market value equal to at least 80% of the balance in the Trust Account (less any Deferred Commissions (as defined below) and taxes payable on interest earned) at the time of the Company signing a definitive agreement in connection with the Business Combination.

If the Company has not completed a Business Combination by October 14, 2018, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable, and less up to $50,000 of interest to pay dissolution expenses) divided by the number of then outstanding public shares, which redemption will completely extinguish the rights of the Public Shareholders as Shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and its Board of Directors, dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. In the event of a liquidation, the Public Shareholders will be entitled to receive a full pro rata interest in the Trust Account (initially anticipated to be approximately $10.00 per share, plus any pro rata interest earned on the Trust Fund not previously released to the Company and less up to $50,000 of interest to pay dissolution expenses). There will be no redemption rights or liquidating distributions with respect to the Founder Shares (as defined below) or the Private Placement Warrants, which will expire worthless if the Company fails to complete a Business Combination within the 24-month time period.

Liquidity

As of March 31, 2017, the Company had $345,377 in cash held outside of the Trust Account available for working capital purposes. In order to preserve liquidity, as of April 30, 2017, the affiliate of the Sponsor (the “Affiliate”) has agreed to defer payment of the monthly administrative fee under the Administrative Services Agreement until the initial Business Combination, at which time all such accrued but unpaid fees will be paid to the Affiliate. If needed to finance ongoing operating expenses, the Sponsor may, but is not obligated to, make working capital loans to the Company, as noted in Note 6.

Based on the foregoing, management believes that the Company will have sufficient working capital to continue as a going concern.

Note 2—Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in U.S dollars in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with US GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all of the information and footnotes necessary for a comprehensive presentation of the financial position, results of operations or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

Table of Contents

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s final prospectus as filed with the SEC on October 10, 2016 and declared effective on October 7, 2016, as well as the Company’s form 8-K, as filed with the SEC on October 20, 2016. Operating results for the three months ended March 31, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017 or any other future period.

Emerging Growth Company

Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

Use of Estimates

The preparation of the Company’s financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, Fair Value Measurements and Disclosures, approximates the carrying amounts represented in the balance sheet.

Fair Value Measurement

ASC 820 establishes a fair value hierarchy that prioritizes and ranks the level of observability of inputs used to measure investments at fair value. The observability of inputs is impacted by a number of factors, including the type of investment, characteristics specific to the investment, market conditions and other factors. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level I measurements) and the lowest priority to unobservable inputs (Level III measurements).

Investments with readily available quoted prices or for which fair value can be measured from quoted prices in active markets will typically have a higher degree of input observability and a lesser degree of judgment applied in determining fair value.

The three levels of the fair value hierarchy under ASC 820 are as follows:

Level I — Quoted prices (unadjusted) in active markets for identical investments at the measurement date are used.

Level II — Pricing inputs are other than quoted prices included within Level I that are observable for the investment, either directly or indirectly. Level II pricing inputs include quoted prices for similar investments in active markets, quoted prices for identical or similar investments in markets that are not active, inputs other than quoted prices that are observable for the investment, and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

Table of Contents

Level III — Pricing inputs are unobservable and include situations where there is little, if any, market activity for the investment. The inputs used in determination of fair value require significant judgment and estimation.

In some cases, the inputs used to measure fair value might fall within different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the investment is categorized in its entirety is determined based on the lowest level input that is significant to the investment. Assessing the significance of a particular input to the valuation of an investment in its entirety requires judgment and considers factors specific to the investment. The categorization of an investment within the hierarchy is based upon the pricing transparency of the investment and does not necessarily correspond to the perceived risk of that investment.

Offering Costs

The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A; “Expenses of Offering”. The Company incurred offering costs in connection with its Public Offering of $833,589, primarily consisting of accounting and legal services, securities registration expenses and exchange listing fees, and excluding $6,200,000 in underwriting discounts and $10,850,000 in deferred underwriting discounts. These offering costs, along with underwriting discounts, were charged to shareholders’ equity.

Net Income Per Share

Net income/(loss) per ordinary share is computed by dividing net income attributable to ordinary shares by the weighted average number of ordinary shares outstanding during the period (excluding 29,490,640 Class A Shares subject to possible redemption as of March 31, 2017 and 1,125,000 Class B Shares subject to forfeiture as of March 31, 2016), plus, to the extent dilutive, the incremental number of Class A Shares to settle the Private Placement Warrants and the Warrants included in the Units. At March 31, 2017, the Company had outstanding warrants for the purchase of up to 23,700,000 Class A Shares. For the period ended March 31, 2017, the weighted average of these shares was excluded from the calculation of diluted net income per ordinary share since the exercise of the warrants is contingent on the occurance of future events. As a result, diluted net income per ordinary share is equal to basic net income/(loss) per ordinary share.

Income Taxes

The Company accounts for income taxes under FASB ASC 740, Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits as of March 31, 2017. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

There is currently no taxation imposed on income by the Government of the Cayman Islands.

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying balance sheet.

Subsequent Events

On April 6, 2017, the Company invested the funds held in the Trust Account in U.S. Treasury Bills maturing on July 6, 2017.

Table of Contents

Other than the foregoing, management has performed an evaluation of subsequent events from March 31, 2017 through the date which these financial statements were issued. Based upon the review, management did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements.

Note 3—Public Offering

In the Public Offering, the Company issued and sold 31,000,000 Units at a price of $10.00 per Unit, including 1,000,000 Units issued upon exercise of the Over-allotment Option. The ordinary shares and warrants comprising the Units began separate trading on November 29, 2016. The holders have the option to continue to hold Units or separate their Units into the component securities. Each Unit consists of one Class A Share and one Warrant to purchase one-half of one Class A Share. Two Warrants must be exercised for one whole Class A Share at a price of $11.50 per share. The Warrants will become exercisable on the later of 30 days after completion of the Business Combination or 12 months after the Close Date and will expire five years from the completion of the Business Combination or earlier upon redemption or liquidation. The Company may redeem the Warrants at a price of $0.01 per Warrant upon 30 days’ notice, only in the event that the last sale price of the Class A Shares is at least $24.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which notice of redemption is given. The Company will not redeem the Warrants unless a registration statement under the Securities Act covering the Class A Shares issuable upon exercise of the Warrants is effective and a current prospectus relating to those shares is available throughout the 30 day redemption period, unless the Warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. If the Company redeems the Warrants as described above, management will have the option to require all holders that wish to exercise their Warrants to do so on a cashless basis, provided an exemption from registration is available. No Warrants will be exercisable for cash unless the Company has an effective registration statement covering the Class A Shares issuable upon exercise of the Warrants and a current prospectus relating to such shares. If the shares issuable upon exercise of the Warrants are not registered under the Securities Act, holders will be permitted to exercise their Warrants on a cashless basis. However, no Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any Class A Shares to holders seeking to exercise their Warrants, unless the issuance of the Class A Shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available.

Note 4—Commitments

Underwriting Agreement

The Company entered into an agreement with the underwriters (the “Underwriters”) of the Public Offering (“Underwriting Agreement”) that required the Company to pay an underwriting discount of 2.0% of the gross proceeds of the Public Offering and Over-allotment Option to the Underwriters at the Close Date of the Public Offering. The Company will pay the Underwriters a deferred underwriting discount of 3.5% of the gross proceeds of the Public Offering and Over-allotment Option (“Deferred Commissions”) at the time of the closing of the Business Combination. The Deferred Commission was placed in the Trust Account at the completion of the Public Offering and will be forfeited if the Company is unable to complete a Business Combination in the prescribed time.

Registration Rights

Holders of the Founder Shares, the Private Placement Warrants, and warrants that may be issued on conversion of working capital loans (and any Class A Shares issuable upon exercise of such warrants and upon conversion of the Founder Shares) will be entitled to registration rights with respect to such securities (in the case of the Founder Shares, only after conversion to Class A Shares) pursuant to an agreement signed on the effective date of the Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities for resale. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Business Combination. However, the registration rights agreement will provide that the Company will not permit any registration statement to become effective until termination of applicable lock-up periods with respect to such securities.

Note 5—Cash Held in Trust Account

Gross proceeds of $310,000,000 and $8,200,000 from the Public Offering and Over-allotment Option, and Private Placement, respectively, less underwriting discounts of $6,200,000 and $2,000,000 designated for offering expenses and to fund the Company’s ongoing administrative and acquisition search costs, were held in the Trust Account at the close date.

Table of Contents

On January 6, 2017, funds held in the Trust Account were invested in US Treasury Bills, which are considered Level 1 investments under ASC 820. For the three months ended March 31, 2017, the investments held in the Trust Account generated interest income of $359,511. At March 31, 2017, the balance of funds held in the Trust Account was $310,359,511.

Note 6—Related Party Transactions

Related Party Loans

The Company issued to the Sponsor on December 14, 2015, as amended and restated on September 1, 2016, an unsecured promissory note pursuant to which the Company was permitted to borrow up to $300,000 in aggregate principal amount. Between inception and the Close Date, the Company borrowed $300,000. This note was non-interest bearing and was repaid in full to the Sponsor at the Close Date.

The Sponsor may make a working capital loan to the Company and up to $1,500,000 of such loan may be converted into warrants, at the price of $0.50 per warrant at the option of the Sponsor. Such warrants would be identical to the Private Placement Warrants.

Administrative Services Agreement

The Company presently occupies office space provided by an Affiliate. The Affiliate has agreed that, until the Company consummates a Business Combination, it will make such office space, as well as certain support services, available to the Company, as may be required by the Company from time to time. The Company will pay the Affiliate an aggregate of $10,000 per month for such office space and support services.

As of April 30, 2017, the Affiliate has agreed to defer payment of the monthly administrative fee under the Administrative Services Agreement until the initial Business Combination, at which time all such accrued but unpaid fees will be paid to the Affiliate.

Private Placement Warrants

The Initial Shareholders purchased 16,000,000 Private Placement Warrants at $0.50 per warrant (for an aggregate purchase price of $8,000,000) from the Company in a Private Placement on the Close Date. A portion of the proceeds from the sale of the Private Placement Warrants were placed into the Trust Account. The Initial Shareholders have also purchased an additional 400,000 Private Placement Warrants at $0.50 per warrant (for an aggregate purchase price of $200,000) simultaneously with the underwriter’s exercise of the Over-Allotment Option. Each Private Placement Warrant is exercisable for one-half of one Class A Share. Two Private Placement Warrants must be exercised for one whole Class A Share at a price of $11.50 per share. The Private Placement Warrants are identical to the Warrants included in the Units to be sold in the Public Offering except that the Private Placement Warrants: (i) will not be redeemable by the Company and (ii) may be exercised for cash or on a cashless basis, as described in the registration statement relating to the Public Offering, so long as they are held by the Initial Shareholders or any of their permitted transferees. Additionally, the Initial Shareholders have agreed not to transfer, assign or sell any of the Private Placement Warrants, including the Class A Shares issuable upon exercise of the Private Placement Warrants (except to certain permitted transferees), until 30 days after the completion of the Business Combination.

Founder Shares

In connection with the organization of the Company, on December 14, 2015, an aggregate of 8,625,000 Class B Shares (the “Founder Shares”) were sold to the Sponsor at a price of approximately $0.003 per share, for an aggregate price of $25,000. In October 2016, the Sponsor transferred 50,000 Founder Shares to each of the Company’s independent directors at a price per share of approximately $0.003 per share. In addition, at such time, each of our independent directors purchased an additional 421,250 Founder Shares from our Sponsor at a price per share of approximately $0.003 per share. The 8,625,000 Founder Shares included an aggregate of up to 1,125,000 shares that were subject to forfeiture if the Over-allotment Option was not exercised in full by the Underwriters in order to maintain the Initial Shareholders’ ownership at 20% of the issued and outstanding Ordinary Shares upon completion of the Public Offering. Following the partial exercise of the Over-allotment Option, 875,000 Founder Shares were forfeited in order to maintain the Initial Shareholder’s ownership at 20% of the issued and outstanding Ordinary shares. The Founder Shares are identical to the Class A Shares included in the Units sold in the Public Offering, except that the Founder Shares (i) have the voting rights described in Note 7, (ii) are subject to certain transfer restrictions described below, and (iii) are convertible into Class A Shares on a one-for-one basis, subject to adjustment pursuant to the anti-dilution provisions contained therein. The Founder Shares may not be transferred, assigned or sold until the earlier of (i) one year after the completion of the Business Combination and (ii) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction after the Business Combination that results in all of the Public Shareholders having the right to exchange their Class A Shares for cash, securities or other property. Notwithstanding the foregoing, if the last sale price of the Class A Shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 trading day period commencing at least 150 days after the Business Combination, the Founder Shares will be released from the lock-up.

Table of Contents

Note 7—Shareholders’ Equity

Preferred Shares

The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.0001. The Company’s board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. The board of directors will be able to, without shareholder approval, issue preferred shares with voting and other rights that could adversely affect the voting power and other rights of the holders of the Ordinary Shares and could have anti-takeover effects. At March 31, 2017 there were no preferred shares issued or outstanding.

Ordinary Shares

The Company is authorized to issue 200,000,000 Class A Shares, with a par value of $0.0001 each, and 20,000,000 Class B ordinary shares, with a par value of $0.0001 each (the “Class B Shares” and, together with the Class A Shares, the “Ordinary Shares”). Holders of the Ordinary Shares are entitled to one vote for each Ordinary Share; provided, that only holders of the Class B Shares have the right to vote on the election of directors prior to the Business Combination. The Class B Shares will automatically convert into Class A Shares at the time of the Business Combination, on a one-for-one basis, subject to adjustment for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A Shares, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Public Offering and related to the closing of the Business Combination, the ratio at which the Class B Shares shall convert into Class A Shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of Class A Shares issuable upon conversion of all Class B Shares will equal, in the aggregate, 20% of the sum of all Ordinary Shares outstanding upon completion of the Public Offering plus all Class A Shares and equity-linked securities issued or deemed issued in connection with the Business Combination, excluding any Ordinary Shares or equity-linked securities issued, or to be issued, to any seller in the Business Combination. Holders of Founder Shares may also elect to convert their Class B Shares into an equal number of Class A Shares, subject to adjustment as provided above, at any time. At March 31, 2017 there were 31,000,000 Class A Shares issued and outstanding, of which 29,490,640 shares were subject to possible redemption and are classified outside of shareholders’ equity at the balance sheet date and 7,750,000 Class B Shares issued and outstanding.

Redeemable Ordinary Shares

The Class A Shares subject to possible redemption will be recorded at redemption value and classified as temporary equity in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 480, Distinguishing Liabilities from Equity. The Company will proceed with a Business Combination only if it has net tangible assets of at least $5,000,001 upon consummation of the Business Combination and, in the case of a shareholder vote, a majority of the outstanding Ordinary Shares voted are voted in favor of the Business Combination. Accordingly, at March 31, 2017, 29,490,640 of the Company’s 31,000,000 Class A Shares were classified outside of permanent equity at their redemption value.

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References in this report (this “Quarterly Report”) to “we,” “us” or the “Company” refer to Avista Healthcare Public Acquisition Corp. References to our “management” or our “management team” refer to our officers and directors, and references to the “sponsor” refer to Avista Acquisition Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those set forth under “Special Note Regarding Forward-Looking Statements,” “Item 1A. Risk Factors” and elsewhere in this Quarterly Report.

Table of Contents

Special Note regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains statements that are forward-looking and as such are not historical facts. This includes, without limitation, statements under “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations. These statements constitute projections, forecasts and forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are not guarantees of performance. They involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by these statements. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this Quarterly Report on Form 10-Q, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. When the Company discusses its strategies or plans, it is making projections, forecasts or forward-looking statements. Such statements are based on the beliefs of, as well as assumptions made by and information currently available to, the Company’s management. Actual results and shareholders’ value will be affected by a variety of risks and factors, including, without limitation, international, national and local economic conditions, merger, acquisition and business combination risks, financing risks, geo-political risks, acts of terror or war, and those risk factors described under “Item 1A. Risk Factors.” Many of the risks and factors that will determine these results and shareholders’ value are beyond the Company’s ability to control or predict.

All such forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. All subsequent written or oral forward-looking statements attributable to us or persons acting on the Company’s behalf are qualified in their entirety by this Special Note Regarding Forward-Looking Statements.

Overview

We are a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a Business Combination in the form of a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more target businesses. We have reviewed, and continue to review, a number of opportunities to enter into a Business Combination with an operating business, but we are not able to determine at this time whether we will complete a Business Combination with any of the businesses that we have reviewed or with any other target business. We intend to effectuate a Business Combination using cash from the proceeds from the Public Offering and the sale of the Private Placement Warrants, and from additional issuances of, if any, our capital stock and debt or a combination of cash, stock and debt. At March 31, 2017, we held cash of $486,200, had current liabilities of $140,823 and deferred underwriting compensation of $10,850,000. Further, we expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

Results of Operations

For the three months ended March 31, 2017 we had net income of $140,863, which consisted of interest income from the trust account of $359,511 and operating costs of $218,648. For the three months ended March 31, 2016 we had a loss of $15,550. Our business activities for the three months ended March 31, 2017 consisted solely of identifying and evaluating prospective acquisition targets for a Business Combination. We will not generate any operating revenues until after completion of our Business Combination at the earliest. Starting in January 2017, we began generating non-operating income in the form of interest income on the funds held in the Trust Account. There has been no significant change in our financial or trading position and no material adverse change has occurred since the date of our financial statements. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses related to our acquisition plans. We believe that we have sufficient funds available to complete our efforts to effect a Business Combination with an operating business by October 14, 2018, which is 24 months from the closing of the Public Offering.

Liquidity and Capital Resources

As of March 31, 2017 we had cash of $486,200 and $345,377 available for working capital purposes.

At March 31, 2017, $310,359,511 was held in the Trust Account and consisted of cash, U.S. Treasury Bills and

Table of Contents

accrued interest. The U.S. Treasury Bills matured on April 6, 2017.

On December 14, 2015, our Sponsor purchased 8,625,000 Founder Shares for an aggregate purchase price of $25,000, or approximately $0.003 per share. In October 2016, our Sponsor transferred 50,000 Founder Shares to each of our independent directors at their original per share purchase price. In addition, at such time, each of our independent directors purchased an additional 421,250 Founder Shares from our Sponsor at their original purchase price.

On October 14, 2016, the Company consummated its Public Offering of 30,000,000 Units, each unit consisting of one Class A ordinary share and one Warrant to purchase one-half of one Class A ordinary share. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $300,000,000. The Company granted the underwriters a 45-day option to purchase up to 4,500,000 additional Units to cover over-allotments, if any. On November 28, 2016, the underwriters partially exercised the Over-allotment Option, and we sold an additional 1,000,000 Units at a price of $10.00 per Unit, generating an additional $10,000,000 of gross proceeds.

On October 14, 2016, simultaneously with the consummation of the Public Offering, the Company completed a private placement of an aggregate of 16,000,000 Private Placement Warrants to the Sponsor and the Company’s independent directors, at a purchase price of $0.50 per warrant, generating gross proceeds of $8,000,000. On November 28, 2016, the Initial Shareholders purchased an additional 400,000 Private Placement Warrants at a price of $0.50 per warrant (or an aggregate purchase price of $200,000) in conjunction with the exercise of the Over-allotment Option. Following the partial exercise of the Over-allotment Option, 875,000 Founder Shares were forfeited in order to maintain the ownership of the Initial Shareholders at 20% of the issued and outstanding ordinary shares. On November 28, 2016, our Sponsor sold 161,180 Founder Shares and 350,114 Private Placement Warrants to one of our independent directors at their original purchase price.

A total of $310,000,000 of the net proceeds from the Public Offering and the sale of the Private Placement Warrants was deposited in the Trust Account established for the benefit of the Company’s public shareholders. Remaining proceeds of approximately $2,000,000 were used to repay the sponsor note and accrued offering and formation costs, and the remainder was deposited in the Company’s operating account and is available for working capital purposes.

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (which interest shall be net of taxes payable and excluding deferred underwriting commissions) to complete our Business Combination. We may withdraw interest to pay taxes, if any. Our annual income tax obligations will depend on the amount of interest and other income earned on the amounts held in the Trust Account. To the extent that our ordinary shares or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

We will use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, structure, negotiate and complete a Business Combination, and to pay taxes to the extent the interest earned on the Trust Account is not sufficient to pay our taxes. Such expenses may be significant, and we expect that a portion of these expenses will be paid upon completion of a Business Combination.

In order to fund working capital deficiencies or finance transaction costs in connection with an intended Business Combination, our sponsor or an Affiliate or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our Business Combination, we would repay such loaned amounts. In the event that our Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants at a price of $0.50 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants issued to our Initial Shareholders. The terms of such loans by our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our Sponsor or an Affiliate as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our Trust Account.

In order to preserve liquidity, as of April 30, 2017, the Affiliate has agreed to defer payment of the monthly administrative fee under the Administrative Services Agreement until the initial Business Combination, at which time all such accrued but unpaid fees will be paid to the Affiliate. We do not believe we will need to raise additional funds during the next 12 months in order to meet the expenditures required for operating our business. However, if our estimates of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain

Table of Contents

additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our Public Shares upon completion of a Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.

We have 24 months after the Close Date to complete a Business Combination. If we do not complete a Business Combination within this time period, we shall (i) cease all operations except for the purposes of winding up, (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest, net of tax (less up to $50,000 of such net interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish the shareholder rights of owners of Class A ordinary shares (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

Off-Balance Sheet Financing Arrangements

As of March 31, 2017, we did not have any obligations, assets or liabilities which would be considered off-balance sheet arrangements. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual Obligations

As of March 31, 2017, we did not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities. On October 10, 2016, we entered into an administrative services agreement pursuant to which have agreed to pay an Affiliate a total of $10,000 per month for office space, administrative and support services. Upon completion of a Business Combination or our liquidation, we will cease paying these monthly fees. We paid an Affiliate $30,000 for such services for the three months ended March 31, 2017. In order to preserve liquidity, as of April 30, 2017, the Affiliate has agreed to defer payment of the monthly administrative fee under the Administrative Services Agreement until the initial Business Combination, at which time all such accrued but unpaid fees will be paid to the Affiliate.

The underwriters are entitled to underwriting commissions of 5.5%, of which 2.0% ($6,200,000) was paid at the closing of the Public Offering and Over-allotment Option, and 3.5% ($10,850,000) was deferred. The deferred underwriting commissions held in the Trust Account will be forfeited in the event we do not complete a Business Combination, subject to the terms of the underwriting agreement. The underwriters are not entitled to any interest accrued on the deferred underwriting commissions.

Critical Accounting Policies

The preparation of condensed financial statements and related disclosures in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. The Company has identified the following as its critical accounting policies:

Offering Costs

The Company complies with the requirements of Accounting Standards Codification (“the ASC”) 340-10-S99-1 and SEC Staff Accounting Bulletin (SAB) Topic 5A — “Expenses of Offering”. We incurred offering costs in connection with the Public Offering of $833,589, primarily consisting of accounting and legal services, securities registration expenses and exchange listing fees. These costs, along with paid and deferred underwriting commissions totaling $17,050,000, were charged to additional paid-in capital at the Close Date.

Table of Contents

Redeemable Ordinary Shares

The Class A ordinary shares subject to possible redemption will be recorded at redemption value and classified as temporary equity in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 480, Distinguishing Liabilities from Equity. The Company will proceed with a Business Combination only if it has net tangible assets of at least $5,000,001 upon consummation of the Business Combination and, in the case of a shareholder vote, a majority of the outstanding ordinary shares voted are voted in favor of the Business Combination. Accordingly, at March 31, 2017, 29,490,640 of the Company’s 31,000,000 Class A ordinary shares were classified outside of permanent equity at their redemption value.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

All activity through March 31, 2017 related to our formation and the preparation for the Public Offering and identifying and evaluating prospective acquisition targets for a Business Combination. On January 6, 2017, the net proceeds of the Public Offering and the sale of the Private Placement Warrants held in the Trust Account were invested in U.S. government treasury bills with a maturity of 180 days or less. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk. For the three months ended March 31, 2017, the effective annualized interest rate earned on our US Treasury Bills investment was 0.508%

At March 31, 2017, $310,359,511 was held in the Trust Account for the purposes of consummating a Business Combination. If we complete a Business Combination within 24 months after the Close Date, funds in the Trust Account will be used to pay for the Business Combination, redemptions of Class A ordinary shares, if any, the deferred underwriting compensation of $10,850,000 and accrued expenses related to the Business Combination. Any funds remaining will be made available to us to provide working capital to finance our operations.

We have not engaged in any hedging activities since our inception. We do not expect to engage in any hedging activities with respect to the market risk to which we are exposed.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in Company reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Evaluation of Disclosure Controls and Procedures

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2017. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were effective.

Changes in Internal Control Over Financial Reporting

During the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

Part II — Other Information

ITEM 1. LEGAL PROCEEDINGS

None.

ITEM 1A. RISK FACTORS

Factors that could cause our actual results to differ materially from those in this report are any of the risks disclosed in our Annual Report on Form 10-K for the year ended December 31, 2016, which was filed with the SEC on March 28, 2017. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.

As of the date of this Quarterly Report on Form 10-Q, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2016, which was filed with the SEC on March 28, 2017. However, we may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On December 14, 2015 our Sponsor purchased 8,625,000 Class B ordinary shares for $25,000, or approximately $0.003 per share. In October 2016, the Sponsor transferred 50,000 Founder Shares to each of the Company’s independent directors at a price per share of approximately $0.003 per share. In addition, at such time, each of our independent directors purchased an additional 421,250 Founder Shares from our Sponsor at a price per share of approximately $0.003 per share.

Simultaneously with the consummation of our Public Offering, the Initial Shareholders purchased from the Company an aggregate of 16,000,000 Private Placement Warrants at a price of $0.50 per Private Placement Warrant (or an aggregate purchase price of $8,000,000). On November 28, 2016, the Initial Shareholders purchased an additional 400,000 Private Placement Warrants at a price of $0.50 per warrant (or an aggregate purchase price of $200,000) in conjunction with the exercise of the Over-allotment Option. Following the partial exercise of the Over-allotment Option, 875,000 Founder Shares were forfeited in order to maintain the Initial Shareholder’s ownership at 20% of the issued and outstanding ordinary shares. On November 28, 2016, our Sponsor sold 161,180 Founder Shares and 350,114 Private Placement Warrants to one of our independent directors at their original per share purchase price. Each Private Placement Warrant entitles the holder to purchase one-half of one Class A ordinary share at $5.75 per one-half share. The Private Placement Warrants have terms and provisions that are identical to those of the Warrants sold as part of the Units in the Public Offering, except that the Private Placement Warrants may be exercised on a cashless basis and are not redeemable by us so long as they are held by the Initial Shareholders or their permitted transferees.

The sales of the above securities by the Company were deemed to be exempt from registration under the Securities Act, in reliance on Section 4(a)(2) of the Securities Act as transactions by an issuer not involving a public offering.

Use of Proceeds from the Offering

On October 14, 2016, we consummated our Public Offering of 30,000,000 Units at a price of $10.00 per Unit. Our Public Offering did not terminate before all of the securities registered in our registration statement were sold. Credit Suisse Securities (USA) LLC and I-Bankers Securities, Inc. acted as underwriters for the offering. The securities sold in the offering were registered under the Securities Act on a registration statement on Form S-1 (File No. 333-213465). The SEC declared the registration statement effective on October 7, 2016. On November 28, 2016, the Underwriters partially exercised the Over-allotment Option, and we sold an additional 1,000,000 Units at a price of $10.00 per Unit.

From Inception through March 31, 2017, we incurred $833,589 for costs and expenses related to the Public Offering. Additionally, at the closing of the Public Offering and Over-allotment Option, we paid a total of $6,200,000 in underwriting discounts and commissions. In addition, the underwriters agreed to defer the payment of $10,850,000 in underwriting discounts and commissions, which amount will be payable upon consummation of our Business Combination, if consummated. Prior to the closing of the Public Offering, our Sponsor loaned us $300,000 to be used for a portion of the expenses of the Public Offering. These loans were repaid upon completion of the Public Offering out of the $900,000 of Public Offering proceeds that were allocated for the payment of offering expenses other than underwriting discounts and commissions. Other than such loans, no payments were made by

Table of Contents

us to directors, officers or persons owning ten percent or more of our ordinary shares or to their associates, or to our affiliates. There has been no material change in the planned use of proceeds from the Public Offering as described in our final prospectus, dated October 10, 2016, filed with the SEC.

After deducting the underwriting discounts and commissions (excluding the deferred portion of $10,850,000 in underwriting commissions, which amount will be payable upon consummation of the Business Combination, if consummated) and the estimated offering expenses, the total net proceeds from the Public Offering and the sale of the Private Placement Warrants were $311,166,411, of which $310,000,000 (or $10.00 per share sold in the Public Offering) was placed in the Trust Account.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. Exhibits

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

Exhibit Number		Description
31.1*		Certification of Chief Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*		Certification of Chief Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*		Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*		Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*		XBRL Instance Document
101.SCH*		XBRL Taxonomy Extension Schema Document
101.CAL*		XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*		XBRL Taxonomy Extension Label Linkbase Document
101.PRE*		XBRL Taxonomy Extension Presentation Linkbase Document

* Filed herewith.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Avista Healthcare Public Acquisition Corp.

Date: May 12, 2017	By:	/s/ David Burgstahler
		David Burgstahler
		Chief Executive Officer (Principal Executive Officer)

Date: May 12, 2017	By:	/s/ John Cafasso
		John Cafasso
		Chief Financial Officer (Principal Financial and Accounting Officer)

Table of Contents

Exhibit Index

Exhibit Number		Description
31.1*		Certification of Chief Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*		Certification of Chief Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*		Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*		Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*		XBRL Instance Document
101.SCH*		XBRL Taxonomy Extension Schema Document
101.CAL*		XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*		XBRL Taxonomy Extension Label Linkbase Document
101.PRE*		XBRL Taxonomy Extension Presentation Linkbase Document

* Filed herewith.

EX-31.1 2 a17-8939_1ex31d1.htm EX-31.1

Exhibit 31.1

CERTIFICATION

I, David Burgstahler, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Avista Healthcare Public Acquisition Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statement made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) [omitted];

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: May 12, 2017


	/s/ David Burgstahler
	David Burgstahler
	President and Chief Executive Officer

EX-31.2 3 a17-8939_1ex31d2.htm EX-31.2

Exhibit 31.2

CERTIFICATION

I, John Cafasso, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Avista Healthcare Public Acquisition Corp.;

(b) [omitted];

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: May 12, 2017

	/s/ John Cafasso
	John Cafasso
	Chief Financial Officer

EX-32.1 4 a17-8939_1ex32d1.htm EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. 1350

(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

I, David Burgstahler, President and Chief Executive Officer of Avista Healthcare Public Acquisition Corp. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to the best of my knowledge:

(1) the Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 31, 2017 (the “Report”) fully complies with the requirements of Section 13 (a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 12, 2017


	/s/ David Burgstahler
	David Burgstahler
	President and Chief Executive Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002) and is not being filed as part of the Report or as a separate disclosure document.

EX-32.2 5 a17-8939_1ex32d2.htm EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. 1350

(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

I, John Cafasso, Chief Financial Officer of Avista Healthcare Public Acquisition Corp. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to the best of my knowledge:

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 12, 2017


	/s/ John Cafasso
	John Cafasso
	Chief Financial Officer

EX-101.INS 6 ahpau-20170331.xml XBRL INSTANCE DOCUMENT 0001661181 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasurySecuritiesMember 2017-03-31 0001661181 ahpau:RelatedPartyLoansMember us-gaap:AffiliatedEntityMember ahpau:UnsecuredPromissoryNoteMember 2015-12-14 2016-10-14 0001661181 ahpau:RelatedPartyLoansMember us-gaap:AffiliatedEntityMember ahpau:UnsecuredPromissoryNoteMember 2015-12-14 0001661181 2016-01-01 2016-03-31 0001661181 ahpau:RelatedPartyLoansMember us-gaap:AffiliatedEntityMember ahpau:WorkingCapitalLoanMember 2017-03-31 0001661181 us-gaap:MaximumMember ahpau:RelatedPartyLoansMember us-gaap:AffiliatedEntityMember ahpau:WorkingCapitalLoanMember 2017-03-31 0001661181 ahpau:FounderSharesTransactionsMember us-gaap:DirectorMember us-gaap:CommonClassBMember 2016-10-31 0001661181 ahpau:FounderSharesTransactionsMember us-gaap:AffiliatedEntityMember us-gaap:CommonClassBMember 2015-12-14 0001661181 us-gaap:CommonClassBMember 2017-03-31 0001661181 us-gaap:CommonClassAMember us-gaap:IPOMember 2016-12-31 0001661181 us-gaap:CommonClassBMember 2016-12-31 0001661181 us-gaap:CommonClassAMember 2016-12-31 0001661181 us-gaap:CommonClassAMember us-gaap:IPOMember 2017-03-31 0001661181 ahpau:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2017-03-31 0001661181 us-gaap:CommonClassAMember us-gaap:IPOMember 2016-10-14 0001661181 ahpau:PrivatePlacementWarrantsMember us-gaap:CommonClassAMember 2017-03-31 0001661181 2016-03-31 0001661181 2015-12-31 0001661181 ahpau:AdministrativeServicesAgreementMember 2017-03-31 0001661181 us-gaap:CommonClassBMember 2017-05-09 0001661181 us-gaap:CommonClassAMember 2017-05-09 0001661181 ahpau:AssetsHeldInTrustMember 2017-01-01 2017-03-31 0001661181 ahpau:AssetsHeldInTrustMember ahpau:OverAllotmentOptionAndPrivatePlacementMember 2016-11-28 2016-11-28 0001661181 us-gaap:IPOMember 2017-01-01 2017-03-31 0001661181 ahpau:IPOOverAllotmentOptionMember 2016-11-28 2016-11-28 0001661181 ahpau:IPOAndIPOOverAllotmentOptionMember 2016-10-14 2016-10-14 0001661181 us-gaap:CommonClassAMember 2017-01-01 2017-03-31 0001661181 us-gaap:CommonClassAMember 2017-03-31 0001661181 us-gaap:CommonClassBMember 2016-01-01 2016-03-31 0001661181 ahpau:FounderSharesTransactionsMember us-gaap:AffiliatedEntityMember 2015-12-14 2015-12-14 0001661181 us-gaap:MaximumMember us-gaap:CommonClassAMember 2017-01-01 2017-03-31 0001661181 ahpau:AssetsHeldInTrustMember us-gaap:MaximumMember 2017-03-31 0001661181 ahpau:IPOOverAllotmentOptionMember 2016-10-14 0001661181 ahpau:IPOOverAllotmentOptionMember 2017-03-31 0001661181 ahpau:RelatedPartyLoansMember us-gaap:AffiliatedEntityMember ahpau:UnsecuredPromissoryNoteMember 2016-10-14 2016-10-14 0001661181 ahpau:OverAllotmentOptionAndPrivatePlacementMember 2016-11-28 2016-11-28 0001661181 us-gaap:CommonClassAMember us-gaap:IPOMember 2017-01-01 2017-03-31 0001661181 us-gaap:CommonClassAMember us-gaap:IPOMember 2016-10-14 2016-10-14 0001661181 us-gaap:MinimumMember 2017-03-31 0001661181 ahpau:FounderSharesTransactionsMember ahpau:InitialShareholdersMember 2016-10-14 0001661181 ahpau:FounderSharesTransactionsMember ahpau:InitialShareholdersMember 2015-12-14 0001661181 ahpau:FounderSharesTransactionsMember us-gaap:AffiliatedEntityMember us-gaap:CommonClassBMember 2016-10-14 2016-10-14 0001661181 ahpau:AssetsHeldInTrustMember us-gaap:MinimumMember 2017-01-01 2017-03-31 0001661181 2017-01-01 2017-03-31 0001661181 2016-12-31 0001661181 us-gaap:CommonClassBMember 2017-01-01 2017-03-31 0001661181 ahpau:PrivatePlacementWarrantsMember 2017-01-01 2017-03-31 0001661181 ahpau:IPOOverAllotmentOptionMember 2017-01-01 2017-03-31 0001661181 us-gaap:MaximumMember ahpau:IPOOverAllotmentOptionMember 2017-03-31 0001661181 2016-10-14 0001661181 ahpau:PrivatePlacementWarrantsMember ahpau:InitialShareholdersMember us-gaap:PrivatePlacementMember 2016-11-28 0001661181 ahpau:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2016-10-14 0001661181 us-gaap:PrivatePlacementMember 2016-10-14 0001661181 ahpau:PrivatePlacementWarrantsMember us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2017-03-31 0001661181 us-gaap:CommonClassAMember 2016-10-14 0001661181 ahpau:PrivatePlacementWarrantsMember ahpau:InitialShareholdersMember us-gaap:PrivatePlacementMember 2016-11-28 2016-11-28 0001661181 us-gaap:PrivatePlacementMember 2016-11-28 2016-11-28 0001661181 ahpau:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2016-10-14 2016-10-14 0001661181 us-gaap:PrivatePlacementMember 2016-10-14 2016-10-14 0001661181 us-gaap:IPOMember 2017-03-31 0001661181 us-gaap:IPOMember 2016-10-14 0001661181 2016-10-14 2016-10-14 0001661181 ahpau:FounderSharesTransactionsMember us-gaap:CommonClassBMember 2017-01-01 2017-03-31 0001661181 2017-03-31 0001661181 us-gaap:IPOMember 2016-10-14 2016-10-14 0001661181 ahpau:FounderSharesTransactionsMember us-gaap:DirectorMember us-gaap:CommonClassBMember 2016-10-01 2016-10-31 ahpau:item xbrli:pure iso4217:USD xbrli:shares iso4217:USD xbrli:shares 421250 833589 345377 12.00 P150D P30D P20D P5Y 1 1 16000000 16000000 400000 400000 2 2 0.50 0.50 0.50 P30D 0.01 4500000 P45D 8200000 200000 8000000 8000000 P12M P30D P30D 1 1 427578 10850000 10850000 10850000 <div> <div> Emerging Growth Company   Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. <div /></div> </div> 0.80 875000 140860 3 0.2 0.20 0.2 24.00 5000001 1 1 1 6200000 200000 300000 0.035 0.035 0.020 0.020 50000 <div> <div> Note 3—Public Offering   In the Public Offering, the Company issued and sold 31,000,000 Units at a price of $10.00 per Unit, including 1,000,000 Units issued upon exercise of the Over-allotment Option. The ordinary shares and warrants comprising the Units began separate trading on November 29, 2016. The holders have the option to continue to hold Units or separate their Units into the component securities. Each Unit consists of one Class A Share and one Warrant to purchase one-half of one Class A Share. Two Warrants must be exercised for one whole Class A Share at a price of $11.50 per share. The Warrants will become exercisable on the later of 30 days after completion of the Business Combination or 12 months after the Close Date and will expire five years from the completion of the Business Combination or earlier upon redemption or liquidation. The Company may redeem the Warrants at a price of $0.01 per Warrant upon 30 days’ notice, only in the event that the last sale price of the Class A Shares is at least $24.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which notice of redemption is given. The Company will not redeem the Warrants unless a registration statement under the Securities Act covering the Class A Shares issuable upon exercise of the Warrants is effective and a current prospectus relating to those shares is available throughout the 30 day redemption period, unless the Warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. If the Company redeems the Warrants as described above, management will have the option to require all holders that wish to exercise their Warrants to do so on a cashless basis, provided an exemption from registration is available. No Warrants will be exercisable for cash unless the Company has an effective registration statement covering the Class A Shares issuable upon exercise of the Warrants and a current prospectus relating to such shares. If the shares issuable upon exercise of the Warrants are not registered under the Securities Act, holders will be permitted to exercise their Warrants on a cashless basis. However, no Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any Class A Shares to holders seeking to exercise their Warrants, unless the issuance of the Class A Shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available. <div /></div> </div> 0.15 P2D P1Y 1125000 1125000 31000000 31000000 31000000 310000000 1000000 30000000 310000000 310000000 10000000 2000000 10.00 10.00 10.00 P30D P20D P10D false --12-31 Q1 2017 2017-03-31 10-Q 0001661181 31000000 7750000 Yes Non-accelerated Filer Avista Healthcare Public Acquisition Corp.

10000

50782

140823

5232937

5092075

23700000

311435911

311239237

1435911

879726

126062

105821

1040068

486200

11.50

0.5

0.0001

220000000

200000000

20000000

220000000

200000000

20000000

8625000

50000

1489245

7750000

1509360

7750000

1489245

7750000

1509360

7750000

25000

149

775

151

775

one vote

1500000

0.50

0.00

0.02

250000

241

359511

15550

90041

-2317

359511

11328360

10990823

311435911

311239237

478360

140823

300000

-20241

-553868

-20000

-427578

-241

-126290

-15550

140863

15550

218648

-15550

-218648

<div> <div> Note 2—Significant Accounting Policies   Basis of Presentation   The accompanying unaudited condensed financial statements have been prepared in U.S dollars in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with US GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all of the information and footnotes necessary for a comprehensive presentation of the financial position, results of operations or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.   The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s final prospectus as filed with the SEC on October 10, 2016 and declared effective on October 7, 2016, as well as the Company’s form 8-K, as filed with the SEC on October 20, 2016. Operating results for the three months ended March 31, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017 or any other future period.   Emerging Growth Company   Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.   Use of Estimates   The preparation of the Company’s financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.   Cash and Cash Equivalents   The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.   Concentration of Credit Risk   Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.   Financial Instruments   The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, Fair Value Measurements and Disclosures, approximates the carrying amounts represented in the balance sheet.   Fair Value Measurement   ASC 820 establishes a fair value hierarchy that prioritizes and ranks the level of observability of inputs used to measure investments at fair value. The observability of inputs is impacted by a number of factors, including the type of investment, characteristics specific to the investment, market conditions and other factors. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level I measurements) and the lowest priority to unobservable inputs (Level III measurements).   Investments with readily available quoted prices or for which fair value can be measured from quoted prices in active markets will typically have a higher degree of input observability and a lesser degree of judgment applied in determining fair value.   The three levels of the fair value hierarchy under ASC 820 are as follows:   Level I — Quoted prices (unadjusted) in active markets for identical investments at the measurement date are used.   Level II — Pricing inputs are other than quoted prices included within Level I that are observable for the investment, either directly or indirectly. Level II pricing inputs include quoted prices for similar investments in active markets, quoted prices for identical or similar investments in markets that are not active, inputs other than quoted prices that are observable for the investment, and inputs that are derived principally from or corroborated by observable market data by correlation or other means.   Level III — Pricing inputs are unobservable and include situations where there is little, if any, market activity for the investment. The inputs used in determination of fair value require significant judgment and estimation.   In some cases, the inputs used to measure fair value might fall within different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the investment is categorized in its entirety is determined based on the lowest level input that is significant to the investment. Assessing the significance of a particular input to the valuation of an investment in its entirety requires judgment and considers factors specific to the investment. The categorization of an investment within the hierarchy is based upon the pricing transparency of the investment and does not necessarily correspond to the perceived risk of that investment.   Offering Costs   The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A; “Expenses of Offering”. The Company incurred offering costs in connection with its Public Offering of $833,589, primarily consisting of accounting and legal services, securities registration expenses and exchange listing fees, and excluding $6,200,000 in underwriting discounts and $10,850,000 in deferred underwriting discounts. These offering costs, along with underwriting discounts, were charged to shareholders’ equity.   Net Income Per Share   Net income/(loss) per ordinary share is computed by dividing net income attributable to ordinary shares by the weighted average number of ordinary shares outstanding during the period (excluding 29,490,640 Class A Shares subject to possible redemption as of March 31, 2017 and 1,125,000 Class B Shares subject to forfeiture as of March 31, 2016), plus, to the extent dilutive, the incremental number of Class A Shares to settle the Private Placement Warrants and the Warrants included in the Units. At March 31, 2017, the Company had outstanding warrants for the purchase of up to 23,700,000 Class A Shares. For the period ended March 31, 2017, the weighted average of these shares was excluded from the calculation of diluted net income per ordinary share since the exercise of the warrants is contingent on the occurance of future events. As a result, diluted net income per ordinary share is equal to basic net income/(loss) per ordinary share.   Income Taxes   The Company accounts for income taxes under FASB ASC 740, Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.   ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits as of March 31, 2017. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.   There is currently no taxation imposed on income by the Government of the Cayman Islands.   Recent Accounting Pronouncements   Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying balance sheet.   Subsequent Events   On April 6, 2017, the Company invested the funds held in the Trust Account in U.S. Treasury Bills maturing on July 6, 2017.   Other than the foregoing, management has performed an evaluation of subsequent events from March 31, 2017 through the date which these financial statements were issued. Based upon the review, management did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements. <div /></div> </div>

<div> <div> Note 1—Organization and Plan of Business Operations   Organization and General   Avista Healthcare Public Acquisition Corp. (the “Company”) was incorporated as a Cayman Islands exempted company on December 4, 2015. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). The Company intends to focus its search for a target business in the healthcare industry, although it may seek to complete a Business Combination with an operating company in any industry or sector. The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (as amended, the “JOBS Act”). The Company’s sponsor is Avista Acquisition Corp. (the “Sponsor”), which was incorporated on December 4, 2015.   At March 31, 2017, the Company had not commenced any operations. All activity through March 31, 2017 relates to the Company’s formation, its initial public offering of 30,000,000 units (the “Units”) at $10.00 per Unit, each consisting of one of the Company’s Class A ordinary shares, par value $0.0001 per share (the “Class A Shares”), and one warrant (the “Warrants”) to purchase one-half of one Class A Share (the “Public Offering”) and efforts directed towards locating a suitable initial Business Combination. The Company also granted the Underwriters (as defined below) of the Public Offering a 45-day option to purchase up to 4,500,000 additional Units to cover over-allotments (the “Over-allotment Option”). The Class A Shares sold as part of the Units in the Public Offering are sometimes referred to herein as the “public shares.” The Company will not generate any operating revenues until after completion of a Business Combination, at the earliest. The Company has selected December 31 as its fiscal year end.   Financing   The registration statement for the Company’s Public Offering was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on October 7, 2016. The Public Offering closed on October 14, 2016 (the “Close Date”). The Sponsor and certain other accredited investors (the “Initial Shareholders”) purchased an aggregate of 16,000,000 warrants (the “Private Placement Warrants”) at a purchase price of $0.50 per warrant, or $8,000,000 in the aggregate, in a private placement at the Close Date (the “Private Placement”).   On November 28, 2016, the Company consummated the closing of the sale of 1,000,000 Units which were sold pursuant to the Over-allotment Option. The Company also consummated a simultaneous private placement of an additional 400,000 Private Placement Warrants with the Initial Shareholders. Following the closing of the Over-allotment Option and Private Placement, an additional $10,000,000 was placed into the Trust Account, after paying additional underwriting discounts of $200,000.   The Company intends to finance a Business Combination with net proceeds from its $310,000,000 Public Offering and $8,200,000 Private Placement (see Note 3). Following the Public Offering, after paying underwriting discounts of $6,200,000 and funds designated for operational use of $2,000,000, the remaining net proceeds of $310,000,000 were deposited in a trust account with Continental Stock Transfer and Trust Company acting as trustee (the “Trust Account”) as described below.   The Trust Account   On January 6, 2017, the funds in the Trust Account were invested in U.S. government treasury bills, which matured on April 6, 2017. On April 6, 2017, the funds in the Trust Account were reinvested in US government treasury bills, maturing on July 6, 2017, until the earlier of (i) the consummation of the Business Combination and (ii) the Company’s failure to consummate a Business Combination within the prescribed time. Placing funds in the Trust Account may not protect those funds from third-party claims against the Company. Although the Company will seek to have all vendors, service providers (other than its independent auditors), prospective target businesses or other entities it engages execute agreements with the Company waiving any claim of any kind in or to any monies held in the Trust Account, there is no guarantee that such persons will execute such agreements. The Sponsor has agreed that it will be liable to the Company under certain circumstances if and to the extent any claims by such persons reduce the amount of funds in the Trust Account below a specified threshold. The Company has not independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believes that the Sponsor’s only assets are securities of the Company. Therefore, the Sponsor may not be able to satisfy those obligations should they arise. The remaining net proceeds (not held in the Trust Account) may be used to pay for business, legal and accounting due diligence on prospective acquisitions and continuing general and administrative expenses as well as any taxes. The balance in the Trust Account as of March 31, 2017 was $310,359,511, of this amount $359,511 was accrued interest.   Business Combination   The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering, the sale of the Private Placement Warrants and the Over-allotment Option, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide the holders of the public shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their public shares upon the completion of the Business Combination, either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer, in either case at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the Business Combination, including interest (which interest shall be net of taxes payable) divided by the number of then outstanding public shares. Notwithstanding the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the public shares. In connection with any shareholder vote required to approve any Business Combination, the Initial Shareholders have agreed (i) to vote any of their respective Ordinary Shares (as defined below) in favor of the Business Combination and (ii) not to redeem any of their Ordinary Shares in connection therewith.   The NASDAQ rules require that the Business Combination must be with one or more target businesses that together have an aggregate fair market value equal to at least 80% of the balance in the Trust Account (less any Deferred Commissions (as defined below) and taxes payable on interest earned) at the time of the Company signing a definitive agreement in connection with the Business Combination.   If the Company has not completed a Business Combination by October 14, 2018, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable, and less up to $50,000 of interest to pay dissolution expenses) divided by the number of then outstanding public shares, which redemption will completely extinguish the rights of the Public Shareholders as Shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and its Board of Directors, dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. In the event of a liquidation, the Public Shareholders will be entitled to receive a full pro rata interest in the Trust Account (initially anticipated to be approximately $10.00 per share, plus any pro rata interest earned on the Trust Fund not previously released to the Company and less up to $50,000 of interest to pay dissolution expenses). There will be no redemption rights or liquidating distributions with respect to the Founder Shares (as defined below) or the Private Placement Warrants, which will expire worthless if the Company fails to complete a Business Combination within the 24-month time period.   Liquidity   As of March 31, 2017, the Company had $345,377 in cash held outside of the Trust Account available for working capital purposes.  In order to preserve liquidity, as of April 30, 2017, the affiliate of the Sponsor (the “Affiliate”) has agreed to defer payment of the monthly administrative fee under the Administrative Services Agreement until the initial Business Combination, at which time all such accrued but unpaid fees will be paid to the Affiliate.  If needed to finance ongoing operating expenses, the Sponsor may, but is not obligated to, make working capital loans to the Company, as noted in Note 6.   Based on the foregoing, management believes that the Company will have sufficient working capital to continue as a going concern. <div /></div> </div>

20000

427578

0.0001

1000000

395843

393526

8200000

300000

310359511

310000000

-233860

-92997

0.003

5000001

5000004

295107550

295248410

0.0001

29510755

29490640

7500000

9239245

29490640

EX-101.SCH 7 ahpau-20170331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00100 - Statement - CONDENSED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Organization and Plan of Business Operations link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Public Offering link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Commitments link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Cash Held in Trust Account link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Organization and Plan of Business Operations - Organization and General (Details) link:presentationLink link:calculationLink link:definitionLink 40102 - Disclosure - Organization and Plan of Business Operations - Financing (Details) link:presentationLink link:calculationLink link:definitionLink 40103 - Disclosure - Organization and Plan of Business Operations - The Trust Account (Details) link:presentationLink link:calculationLink link:definitionLink 40104 - Disclosure - Organization and Plan of Business Operations - Business Combination and Liquidity (Details) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Public Offering (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Cash Held in Trust Account (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Related Party Transactions - Related Party Loans and Administrative Services Agreement (Details) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - Related Party Transactions - Private Placement Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 40603 - Disclosure - Related Party Transactions - Founder Shares (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Shareholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 ahpau-20170331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 ahpau-20170331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 ahpau-20170331_lab.xml XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT Document and Entity Information Statement [Table] Statement [Line Items] Statement Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Current Reporting Status Entity Filer Category Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus CONDENSED BALANCE SHEETS Assets [Abstract] ASSETS Assets, Current [Abstract] Current assets Cash Cash at end of period Cash at beginning of period Prepaid Expense, Current Prepaid expenses Assets, Current Total current assets Interest Receivable, Noncurrent Accrued interest receivable held in trust account Restricted Investments, Noncurrent Cash and cash equivalents held in trust account Assets Total assets Liabilities and Equity [Abstract] LIABILITIES AND SHAREHOLDERS' EQUITY/(DEFICIT) Liabilities, Current [Abstract] Current liabilities Represents the specific incremental costs payable directly attributable to a proposed or actual offering of securities. Deferred Offering Costs Payable Offering costs payable Accrued Liabilities, Current Accrued expenses Liabilities, Current Total current liabilities Represents the deferred portion of underwriting discounts and commissions. Deferred Underwriting Commission Deferred underwriting commission Liabilities Total liabilities Commitments and Contingencies COMMITMENTS Temporary Equity, Carrying Amount, Attributable to Parent Class A ordinary shares subject to possible redemption, $0.0001 par value; 29,490,640 and 29,510,755 shares at conversion value at March 31, 2017 and December 31, 2016 Stockholders' Equity Attributable to Parent [Abstract] Shareholders' equity Preferred Stock, Value, Issued Preferred shares, $0.0001 par value, 1,000,000 shares authorized: no shares issued and outstanding at March 31, 2017 and December 31, 2016 Common Stock, Value, Issued Ordinary shares, value Additional Paid in Capital, Common Stock Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders' Equity Attributable to Parent Total shareholders' equity Liabilities and Equity Total liabilities and shareholders' equity Temporary Equity, Par or Stated Value Per Share Class A ordinary shares subject to possible redemption, par value Temporary Equity, Shares Issued Class A ordinary shares subject to possible redemption, shares issued Ordinary shares subject to redemption, shares issued Preferred Stock, Par or Stated Value Per Share Preferred shares, par value (in dollar per share) Preferred Stock, Shares Authorized Preferred shares, shares authorized Preferred Stock, Shares Issued Preferred shares, shares issued Preferred Stock, Shares Outstanding Preferred shares, shares outstanding Common Stock, Par or Stated Value Per Share Par value of common stock (in dollars per share) Ordinary shares, par value (in dollar per share) Common Stock, Shares Authorized Ordinary shares, shares authorized Common Stock, Shares, Issued Ordinary shares, shares issued Common Stock, Shares, Outstanding Ordinary shares, shares outstanding Represents shares forfeited as a result of partial exercise of underwriters' over-allotment option. Forfeiture Of Shares, Shares Shares forfeited CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) Operating Expenses Operating costs Operating Income (Loss) Loss from operations Nonoperating Income (Expense) [Abstract] Other income: Investment Income, Interest Interest income Net Income (Loss) Attributable to Parent Net income/(loss) Net income/(loss) Weighted Average Number of Shares Outstanding, Basic and Diluted Weighted average number of shares outstanding, basic and diluted (in shares) Earnings Per Share, Basic and Diluted Basic and diluted net income/(loss) per share CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Cash flows from operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income to net cash used in operating activities: Increase (Decrease) in Operating Capital [Abstract] Change in operating assets and liabilities: Increase (Decrease) in Accrued Interest Receivable, Net Accrued interest receivable held in trust account Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Prepaid Expense Prepaid expenses Increase (Decrease) in Accrued Liabilities Accrued expenses Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net cash used in operating activities: Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Cash flows from financing activities: Payments of Stock Issuance Costs Payment of offering costs Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net cash used in financing activities: Net Cash Provided by (Used in) Continuing Operations Net decrease in cash Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental disclosure of non-cash financing activities: The increase (decrease) during the period in the carrying amount of temporary equity ordinary shares subject to possible redemption. Increase (Decrease) In Temporary Equity, Ordinary Shares Subject To Possible Redemption Change in ordinary shares subject to possible redemption Organization and Plan of Business Operations Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Organization and Plan of Business Operations Significant Accounting Policies Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Significant Accounting Policies n/a Public Offering The entire disclosure for public offering. Public Offering [Text Block] Public Offering Commitments Commitments and Contingencies Disclosure [Text Block] Commitments Cash Held in Trust Account Cash and Cash Equivalents Disclosure [Text Block] Cash Held in Trust Account Related Party Transactions Related Party Transactions Disclosure [Text Block] Related Party Transactions Shareholders' Equity Stockholders' Equity Note Disclosure [Text Block] Shareholders' Equity Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Disclosure of accounting policy for emerging growth companies. Emerging Growth Company [Policy Text Block] Emerging Growth Company Use of Estimates, Policy [Policy Text Block] Use of Estimates Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risk Fair Value of Financial Instruments, Policy [Policy Text Block] Financial Instruments Fair Value Measurement, Policy [Policy Text Block] Fair Value Measurement Deferred Charges, Policy [Policy Text Block] Offering Costs Earnings Per Share, Policy [Policy Text Block] Net Income Per Share Income Tax, Policy [Policy Text Block] Income Taxes New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Subsequent Events, Policy [Policy Text Block] Subsequent Events Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary, Sale of Stock [Line Items] Organization and Financing Public Offering Number of new units issued during the period. Units Issued During Period Units New Issues Sale of units Per share or per unit amount of units issued. Units Issued Price Per Share Price of units (in dollars per unit) Represents the number of shares of common stock included in each unit. Number of Shares of Common Stock Included in Each Unit Number of shares of common stock included in each unit Represents the number of warrants included in each unit. Class of Warrant or Right, Number of Warrants Included in Each Unit Number of warrants included in each unit Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Number of shares called by each warrant Represents the number of days in which underwriters may purchase additional units. Class of Warrant or Right, Underwriters Purchase Option Term Term of option to purchase additional units Represents the number of additional units that may be purchased by underwriters. Class of Warrant or Right, Underwriters Purchase Option Number of Units Additional units available for purchase Revenue, Net Revenue Number of warrants issued during the period Class Of Warrant Or Right Number Of Warrants Issued Warrants issued (in shares) Purchase price per share or per unit of warrants or rights Class Of Warrant Or Right Purchase Price Of Warrants Or Rights Purchase price of warrants Aggregate value of warrants issued during the period, net of proceeds reserved for operations. Class Of Warrant Or Right Value Of Warrants Issued, Net of Proceeds Reserved For Operations Aggregate value of warrants, net of proceeds reserved for operations Aggregate value of warrants issued during the period. Class Of Warrant Or Right Value Of Warrants Issued Aggregate value of warrants Represents the net proceeds from the sale if units. Units Issued Net Proceeds Net proceeds from sale of units Represents the payment of underwriting discounts Payment of Underwriting Discounts Payment of underwriting discounts Underwriting discounts Represents the amount of proceeds from the sale of units that have been reserved for operational use. Units Issued Portion of Gross Proceeds Reserved for Operations Funds designated for operational use Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities [Line Items] The Trust Account Restricted Cash and Cash Equivalents Cash balance in the Trust Account Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Business Combination The period of time which the reporting entity must provide stockholders prior to the consummation of the Business Combination to redeem stock or sell to the reporting entity. Redemption Period Prior to Consummation of Business Combination Business combination, redemption valuation period prior to consummation Represents the percent of aggregate public shares that may be redeemed by a Public Shareholder. Redemption of Public Shares Percentage of Aggregate Shares Percent of aggregate public shares that may be redeemed by a shareholder The number of businesses expected to be included in the Business Combination, as defined for the release of assets held in trust. Number of Businesses Included Business Combination Number of target businesses for Business Combination The fair market value of the Business Combination, percentage of assets held in trust. Fair Market Value Business Combination Percentage of Assets Held in Trust Business combination, fair value percent of assets held in trust The maximum period of time subsequent to the specified period in time within which the reporting entity must complete the Business Combination which the entity has to wind up. Wind Up Period, If Business Combination Not Completed Uncompleted business combination, wind-up period The portion of the interest income from the assets held in trust which are permitted to be used to pay dissolution expenses in the event the entity is dissolved failing completion of an Business Combination. Portion of Trust Funds Allocated for Dissolution Expenses Portion of interest income allowed to pay dissolution expenses n/a Liquidity [Abstract] Liquidity The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-outside-trust will be released or forfeited. Assets Held-outside-trust, Current Cash held outside of the Trust Account available for working capital Represents information pertaining to significant accounting policies Significant Accounting Policies [Table] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Significant Accounting Policies [Line Items] Significant Accounting Policies n/a Concentration Risk, Credit Risk, Financial Instruments [Abstract] Concentration of Credit Risk FDIC Indemnification Asset Federal depository insurance coverage Deferred Costs, Current [Abstract] Offering Costs Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing warrants. Adjustments To Additional Paid In Capital Warrants Issued Offering Costs Offering Costs Future cash outflow to pay underwriting compensation. Deferred Underwriting Compensation Incurred But Not Yet Paid Deferred underwriting commission Earnings Per Share [Abstract] Net Income Per Share Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation Ordinary shares subject to possible redemption, shares issued Represents the number of shares subject to forfeiture if certain conditions are met. Shares Subject to Forfeiture Shares subject to forfeiture Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Outstanding warrants to purchase Class A Shares Income Tax Expense (Benefit), Continuing Operations [Abstract] Income Taxes Unrecognized Tax Benefits Unrecognized tax benefits Represents the number of warrants that must be exercised for one whole share of Class A common stock. Class of Warrant or Right, Number Warrants Required for Conversion Per Share of Common Stock Number of warrants required for conversion to one whole share Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price Represents the period after the completion of the Business Combination during which warrants will be exercisable. Class of Warrant or Right, Warrant Exercisable Period After Completion of Initial Business Combination Period after the completion of the Business Combination for exercise of warrants (in days) Represents the period from the closing of the Public Offering during which warrants will be exercisable. Class of Warrant or Right Warrant Exercisable Period After Closing of Public Offering Period from closing of Public Offering for exercise of warrants (in months) Represents information pertaining to class of warrant expiration period after completion of business combination. Class of Warrant or Right, Expiration Period After Completion of Business Combination Expiration period of warrants after completion of the Business Combination Represents the price at which the Company may redeem warrants. Class of Warrant or Right, Redemption Price of Warrants or Rights Redemption price per warrant Represents the number of days notice the Company must give warrant holders before redemption. Class of Warrant or Right, Redemption Notice Period Redemption notice period Represents the minimum share price of Class A common stock required to trigger eligibility of Company redemption of warrants. Minimum Price Per Share Required for Redemption of Warrants Minimum price per share required for redemption of warrants Threshold number of specified trading days for warrants redemption. Warrants Redemption Covenant Threshold Trading Days Warrants redemption covenant, threshold trading days Threshold period of specified consecutive trading days for warrants redemption. Warrants Redemption Covenant Threshold Consecutive Trading Days Warrants redemption covenant, threshold consecutive trading days n/a Underwriting Agreement [Abstract] Underwriting Agreement Percentage of gross proceeds payable to the underwriters on the Close Date of the Public Offering. Percentage of Underwriting Discount Payable Underwriting discount Percentage of gross proceeds payable to the underwriters upon the closing of the Business Combination. Percentage of Deferred Underwriting Discount Payable Deferred underwriting discount n/a Registration Rights [Abstract] Registration Rights Represents the maximum number of demands rights holders may make that the Company register converted shares. Maximum Number of Demands Allowed by Rights Holders Maximum number of demands Schedule of Restricted Cash and Cash Equivalents [Table] Restricted Cash and Cash Equivalents Items [Line Items] Cash Held in Trust Account Proceeds from Issuance of Warrants Proceeds from issuance of Private Placement Warrants Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Related Party Transactions Line of Credit Facility, Maximum Borrowing Capacity Promissory note, maximum borrowing capacity Proceeds from Lines of Credit Amount borrowed between inception and the Close Date The cash outflow from a short-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Payments To Related Party Short Term Debt Repayment of note payable to Sponsor Convertible Debt Portion of working capital loan that may be converted into warrants Debt Instrument, Convertible, Conversion Price Conversion price per warrant Accounts Payable, Related Parties Monthly payment for office space and support services Shares Issued, Price Per Share Price per share Purchased an additional common stock shares during the period Additional Purchase of Common Stock, Shares Additional purchase of ordinary shares Represents the minimum percentage of ownership the Initial Shareholders must maintain of total issued and outstanding ordinary shares to prevent forfeiture of certain quantities of Class B shares. Minimum Ownership Percentage Of Ordinary Shares Minimum ownership of ordinary shares by initial shareholders (as a percent) Ratio applied to the conversion of ordinary common stock from Class B to Class A. Conversion Of Stock, Conversion Ratio Ratio of conversion from Class B to Class A ordinary shares Represents the period of time after completion of the Business Combination in which Founder Shares may not be transferred, assigned or sold. Restriction To Transfer Class B Ordinary Shares, Term Restriction to transfer Class B ordinary shares (in years) Minimum price per share of Class B ordinary shares required (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) to release Founder Shares from transfer of ownership restrictions. Class B Ordinary Shares Redemption Covenant Minimum Price Per Share Founder Shares redemption covenant, minimum price per share Threshold number of specified trading days for Class B ordinary shares redemption. Class B Ordinary Shares Redemption Covenant Threshold Trading Days Founder Shares redemption covenant, threshold trading days Threshold period of specified consecutive trading days for Class B ordinary shares redemption. Class B Ordinary Shares Redemption Covenant Threshold Consecutive Trading Days Founder Shares redemption covenant, threshold consecutive trading days Minimum period of time after completion of the Business Combination after which Founder Shares may be transferred, assigned or sold, if certain conditions are met. Class B Ordinary Shares Redemption Covenant Minimum Restriction Term Founder Shares redemption covenant, minimum restriction term (in days) Schedule of Stock by Class [Table] Class of Stock [Line Items] Shareholders' Equity Common Stock, Voting Rights Ordinary shares, voting rights per share Represents the total temporary equity and common stock shares issued as of the balance sheet date. Temporary Equity And Common Stock, Shares Issued Total ordinary shares issued, including shares subject to redemption Represents the total temporary equity and common stock shares outstanding as of the balance sheet date. Temporary Equity And Common Stock, Shares Outstanding Total ordinary shares outstanding, including shares subject to redemption Temporary Equity, Shares Outstanding Ordinary shares subject to redemption, shares outstanding Represents Net Tangible Assets of the entity as of the balance sheet date. Net Tangible Assets Net tangible assets Class of Stock [Axis] Class Of Stock [Domain] Class of Stock [Domain] Common Class A [Member] Class A Common Class B [Member] Class B Sale of Stock [Axis] Sale Of Stock Name Of Transaction [Domain] Sale of Stock [Domain] I P O [Member] IPO Right given to the underwriter of the IPO to sell additional shares over the allotment. I P O Over Allotment Option [Member] Over-Allotment Option Range [Axis] Range [Member] Range [Domain] EX-101.PRE 11 ahpau-20170331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2017	May 09, 2017
Entity Registrant Name	Avista Healthcare Public Acquisition Corp.
Entity Central Index Key	0001661181
Document Type	10-Q
Document Period End Date	Mar. 31, 2017
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q1
Class A
Entity Common Stock, Shares Outstanding		31,000,000
Class B
Entity Common Stock, Shares Outstanding		7,750,000

XML 13 R2.htm IDEA: XBRL DOCUMENT

CONDENSED BALANCE SHEETS - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Current assets
Cash	$ 486,200	$ 1,040,068
Prepaid expenses	393,526	395,843
Total current assets	879,726	1,435,911
Accrued interest receivable held in trust account	359,511
Cash and cash equivalents held in trust account	310,000,000	310,000,000
Total assets	311,239,237	311,435,911
Current liabilities
Offering costs payable		427,578
Accrued expenses	140,823	50,782
Total current liabilities	140,823	478,360
Deferred underwriting commission	10,850,000	10,850,000
Total liabilities	10,990,823	11,328,360
COMMITMENTS
Class A ordinary shares subject to possible redemption, $0.0001 par value; 29,490,640 and 29,510,755 shares at conversion value at March 31, 2017 and December 31, 2016	295,248,410	295,107,550
Shareholders' equity
Preferred shares, $0.0001 par value, 1,000,000 shares authorized: no shares issued and outstanding at March 31, 2017 and December 31, 2016
Additional paid-in capital	5,092,075	5,232,937
Accumulated deficit	(92,997)	(233,860)
Total shareholders' equity	5,000,004	5,000,001
Total liabilities and shareholders' equity	311,239,237	311,435,911
Class A
Shareholders' equity
Ordinary shares, value	151	149
Class B
Shareholders' equity
Ordinary shares, value	$ 775	$ 775

XML 14 R3.htm IDEA: XBRL DOCUMENT

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2017	Dec. 31, 2016
Class A ordinary shares subject to possible redemption, par value	$ 0.0001	$ 0.0001
Class A ordinary shares subject to possible redemption, shares issued	29,490,640	29,510,755
Preferred shares, par value (in dollar per share)	$ 0.0001	$ 0.0001
Preferred shares, shares authorized	1,000,000	1,000,000
Preferred shares, shares issued	0	0
Preferred shares, shares outstanding	0	0
Ordinary shares, par value (in dollar per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	220,000,000	220,000,000
Class A
Ordinary shares, par value (in dollar per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	200,000,000	200,000,000
Ordinary shares, shares issued	1,509,360	1,489,245
Ordinary shares, shares outstanding	1,509,360	1,489,245
Class B
Ordinary shares, par value (in dollar per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	20,000,000	20,000,000
Ordinary shares, shares issued	7,750,000	7,750,000
Ordinary shares, shares outstanding	7,750,000	7,750,000

XML 15 R4.htm IDEA: XBRL DOCUMENT

CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)
Operating costs	$ (218,648)	$ (15,550)
Loss from operations	(218,648)	(15,550)
Other income:
Interest income	359,511
Net income/(loss)	$ 140,863	$ (15,550)
Weighted average number of shares outstanding, basic and diluted (in shares)	9,239,245	7,500,000
Basic and diluted net income/(loss) per share	$ 0.02	$ 0.00

XML 16 R5.htm IDEA: XBRL DOCUMENT

CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net income/(loss)	$ 140,863	$ (15,550)
Change in operating assets and liabilities:
Accrued interest receivable held in trust account	(359,511)
Accounts receivable		(241)
Prepaid expenses	2,317
Accrued expenses	90,041	15,550
Net cash used in operating activities:	(126,290)	(241)
Cash flows from financing activities:
Payment of offering costs	(427,578)	(20,000)
Net cash used in financing activities:	(427,578)	(20,000)
Net decrease in cash	(553,868)	(20,241)
Cash at beginning of period	1,040,068	126,062
Cash at end of period	486,200	$ 105,821
Supplemental disclosure of non-cash financing activities:
Change in ordinary shares subject to possible redemption	$ 140,860

XML 17 R6.htm IDEA: XBRL DOCUMENT

Organization and Plan of Business Operations	3 Months Ended
Organization and Plan of Business Operations	Mar. 31, 2017
Organization and Plan of Business Operations
Organization and Plan of Business Operations	Note 1—Organization and Plan of Business Operations Organization and General Avista Healthcare Public Acquisition Corp. (the “Company”) was incorporated as a Cayman Islands exempted company on December 4, 2015. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). The Company intends to focus its search for a target business in the healthcare industry, although it may seek to complete a Business Combination with an operating company in any industry or sector. The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (as amended, the “JOBS Act”). The Company’s sponsor is Avista Acquisition Corp. (the “Sponsor”), which was incorporated on December 4, 2015. At March 31, 2017, the Company had not commenced any operations. All activity through March 31, 2017 relates to the Company’s formation, its initial public offering of 30,000,000 units (the “Units”) at $10.00 per Unit, each consisting of one of the Company’s Class A ordinary shares, par value $0.0001 per share (the “Class A Shares”), and one warrant (the “Warrants”) to purchase one-half of one Class A Share (the “Public Offering”) and efforts directed towards locating a suitable initial Business Combination. The Company also granted the Underwriters (as defined below) of the Public Offering a 45-day option to purchase up to 4,500,000 additional Units to cover over-allotments (the “Over-allotment Option”). The Class A Shares sold as part of the Units in the Public Offering are sometimes referred to herein as the “public shares.” The Company will not generate any operating revenues until after completion of a Business Combination, at the earliest. The Company has selected December 31 as its fiscal year end. Financing The registration statement for the Company’s Public Offering was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on October 7, 2016. The Public Offering closed on October 14, 2016 (the “Close Date”). The Sponsor and certain other accredited investors (the “Initial Shareholders”) purchased an aggregate of 16,000,000 warrants (the “Private Placement Warrants”) at a purchase price of $0.50 per warrant, or $8,000,000 in the aggregate, in a private placement at the Close Date (the “Private Placement”). On November 28, 2016, the Company consummated the closing of the sale of 1,000,000 Units which were sold pursuant to the Over-allotment Option. The Company also consummated a simultaneous private placement of an additional 400,000 Private Placement Warrants with the Initial Shareholders. Following the closing of the Over-allotment Option and Private Placement, an additional $10,000,000 was placed into the Trust Account, after paying additional underwriting discounts of $200,000. The Company intends to finance a Business Combination with net proceeds from its $310,000,000 Public Offering and $8,200,000 Private Placement (see Note 3). Following the Public Offering, after paying underwriting discounts of $6,200,000 and funds designated for operational use of $2,000,000, the remaining net proceeds of $310,000,000 were deposited in a trust account with Continental Stock Transfer and Trust Company acting as trustee (the “Trust Account”) as described below. The Trust Account On January 6, 2017, the funds in the Trust Account were invested in U.S. government treasury bills, which matured on April 6, 2017. On April 6, 2017, the funds in the Trust Account were reinvested in US government treasury bills, maturing on July 6, 2017, until the earlier of (i) the consummation of the Business Combination and (ii) the Company’s failure to consummate a Business Combination within the prescribed time. Placing funds in the Trust Account may not protect those funds from third-party claims against the Company. Although the Company will seek to have all vendors, service providers (other than its independent auditors), prospective target businesses or other entities it engages execute agreements with the Company waiving any claim of any kind in or to any monies held in the Trust Account, there is no guarantee that such persons will execute such agreements. The Sponsor has agreed that it will be liable to the Company under certain circumstances if and to the extent any claims by such persons reduce the amount of funds in the Trust Account below a specified threshold. The Company has not independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believes that the Sponsor’s only assets are securities of the Company. Therefore, the Sponsor may not be able to satisfy those obligations should they arise. The remaining net proceeds (not held in the Trust Account) may be used to pay for business, legal and accounting due diligence on prospective acquisitions and continuing general and administrative expenses as well as any taxes. The balance in the Trust Account as of March 31, 2017 was $310,359,511, of this amount $359,511 was accrued interest. Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering, the sale of the Private Placement Warrants and the Over-allotment Option, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide the holders of the public shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their public shares upon the completion of the Business Combination, either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer, in either case at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the Business Combination, including interest (which interest shall be net of taxes payable) divided by the number of then outstanding public shares. Notwithstanding the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the public shares. In connection with any shareholder vote required to approve any Business Combination, the Initial Shareholders have agreed (i) to vote any of their respective Ordinary Shares (as defined below) in favor of the Business Combination and (ii) not to redeem any of their Ordinary Shares in connection therewith. The NASDAQ rules require that the Business Combination must be with one or more target businesses that together have an aggregate fair market value equal to at least 80% of the balance in the Trust Account (less any Deferred Commissions (as defined below) and taxes payable on interest earned) at the time of the Company signing a definitive agreement in connection with the Business Combination. If the Company has not completed a Business Combination by October 14, 2018, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable, and less up to $50,000 of interest to pay dissolution expenses) divided by the number of then outstanding public shares, which redemption will completely extinguish the rights of the Public Shareholders as Shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and its Board of Directors, dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. In the event of a liquidation, the Public Shareholders will be entitled to receive a full pro rata interest in the Trust Account (initially anticipated to be approximately $10.00 per share, plus any pro rata interest earned on the Trust Fund not previously released to the Company and less up to $50,000 of interest to pay dissolution expenses). There will be no redemption rights or liquidating distributions with respect to the Founder Shares (as defined below) or the Private Placement Warrants, which will expire worthless if the Company fails to complete a Business Combination within the 24-month time period. Liquidity As of March 31, 2017, the Company had $345,377 in cash held outside of the Trust Account available for working capital purposes. In order to preserve liquidity, as of April 30, 2017, the affiliate of the Sponsor (the “Affiliate”) has agreed to defer payment of the monthly administrative fee under the Administrative Services Agreement until the initial Business Combination, at which time all such accrued but unpaid fees will be paid to the Affiliate. If needed to finance ongoing operating expenses, the Sponsor may, but is not obligated to, make working capital loans to the Company, as noted in Note 6. Based on the foregoing, management believes that the Company will have sufficient working capital to continue as a going concern.

XML 18 R7.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies	3 Months Ended
Significant Accounting Policies	Mar. 31, 2017
Significant Accounting Policies
Significant Accounting Policies	Note 2—Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in U.S dollars in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with US GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all of the information and footnotes necessary for a comprehensive presentation of the financial position, results of operations or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s final prospectus as filed with the SEC on October 10, 2016 and declared effective on October 7, 2016, as well as the Company’s form 8-K, as filed with the SEC on October 20, 2016. Operating results for the three months ended March 31, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017 or any other future period. Emerging Growth Company Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. Use of Estimates The preparation of the Company’s financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, Fair Value Measurements and Disclosures, approximates the carrying amounts represented in the balance sheet. Fair Value Measurement ASC 820 establishes a fair value hierarchy that prioritizes and ranks the level of observability of inputs used to measure investments at fair value. The observability of inputs is impacted by a number of factors, including the type of investment, characteristics specific to the investment, market conditions and other factors. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level I measurements) and the lowest priority to unobservable inputs (Level III measurements). Investments with readily available quoted prices or for which fair value can be measured from quoted prices in active markets will typically have a higher degree of input observability and a lesser degree of judgment applied in determining fair value. The three levels of the fair value hierarchy under ASC 820 are as follows: Level I — Quoted prices (unadjusted) in active markets for identical investments at the measurement date are used. Level II — Pricing inputs are other than quoted prices included within Level I that are observable for the investment, either directly or indirectly. Level II pricing inputs include quoted prices for similar investments in active markets, quoted prices for identical or similar investments in markets that are not active, inputs other than quoted prices that are observable for the investment, and inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level III — Pricing inputs are unobservable and include situations where there is little, if any, market activity for the investment. The inputs used in determination of fair value require significant judgment and estimation. In some cases, the inputs used to measure fair value might fall within different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the investment is categorized in its entirety is determined based on the lowest level input that is significant to the investment. Assessing the significance of a particular input to the valuation of an investment in its entirety requires judgment and considers factors specific to the investment. The categorization of an investment within the hierarchy is based upon the pricing transparency of the investment and does not necessarily correspond to the perceived risk of that investment. Offering Costs The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A; “Expenses of Offering”. The Company incurred offering costs in connection with its Public Offering of $833,589, primarily consisting of accounting and legal services, securities registration expenses and exchange listing fees, and excluding $6,200,000 in underwriting discounts and $10,850,000 in deferred underwriting discounts. These offering costs, along with underwriting discounts, were charged to shareholders’ equity. Net Income Per Share Net income/(loss) per ordinary share is computed by dividing net income attributable to ordinary shares by the weighted average number of ordinary shares outstanding during the period (excluding 29,490,640 Class A Shares subject to possible redemption as of March 31, 2017 and 1,125,000 Class B Shares subject to forfeiture as of March 31, 2016), plus, to the extent dilutive, the incremental number of Class A Shares to settle the Private Placement Warrants and the Warrants included in the Units. At March 31, 2017, the Company had outstanding warrants for the purchase of up to 23,700,000 Class A Shares. For the period ended March 31, 2017, the weighted average of these shares was excluded from the calculation of diluted net income per ordinary share since the exercise of the warrants is contingent on the occurance of future events. As a result, diluted net income per ordinary share is equal to basic net income/(loss) per ordinary share. Income Taxes The Company accounts for income taxes under FASB ASC 740, Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits as of March 31, 2017. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying balance sheet. Subsequent Events On April 6, 2017, the Company invested the funds held in the Trust Account in U.S. Treasury Bills maturing on July 6, 2017. Other than the foregoing, management has performed an evaluation of subsequent events from March 31, 2017 through the date which these financial statements were issued. Based upon the review, management did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements.

XML 19 R8.htm IDEA: XBRL DOCUMENT

Public Offering	3 Months Ended
Public Offering	Mar. 31, 2017
Public Offering
Public Offering	Note 3—Public Offering In the Public Offering, the Company issued and sold 31,000,000 Units at a price of $10.00 per Unit, including 1,000,000 Units issued upon exercise of the Over-allotment Option. The ordinary shares and warrants comprising the Units began separate trading on November 29, 2016. The holders have the option to continue to hold Units or separate their Units into the component securities. Each Unit consists of one Class A Share and one Warrant to purchase one-half of one Class A Share. Two Warrants must be exercised for one whole Class A Share at a price of $11.50 per share. The Warrants will become exercisable on the later of 30 days after completion of the Business Combination or 12 months after the Close Date and will expire five years from the completion of the Business Combination or earlier upon redemption or liquidation. The Company may redeem the Warrants at a price of $0.01 per Warrant upon 30 days’ notice, only in the event that the last sale price of the Class A Shares is at least $24.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which notice of redemption is given. The Company will not redeem the Warrants unless a registration statement under the Securities Act covering the Class A Shares issuable upon exercise of the Warrants is effective and a current prospectus relating to those shares is available throughout the 30 day redemption period, unless the Warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. If the Company redeems the Warrants as described above, management will have the option to require all holders that wish to exercise their Warrants to do so on a cashless basis, provided an exemption from registration is available. No Warrants will be exercisable for cash unless the Company has an effective registration statement covering the Class A Shares issuable upon exercise of the Warrants and a current prospectus relating to such shares. If the shares issuable upon exercise of the Warrants are not registered under the Securities Act, holders will be permitted to exercise their Warrants on a cashless basis. However, no Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any Class A Shares to holders seeking to exercise their Warrants, unless the issuance of the Class A Shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available.

XML 20 R9.htm IDEA: XBRL DOCUMENT

Commitments	3 Months Ended
Commitments	Mar. 31, 2017
Commitments
Commitments	Note 4—Commitments Underwriting Agreement The Company entered into an agreement with the underwriters (the “Underwriters”) of the Public Offering (“Underwriting Agreement”) that required the Company to pay an underwriting discount of 2.0% of the gross proceeds of the Public Offering and Over-allotment Option to the Underwriters at the Close Date of the Public Offering. The Company will pay the Underwriters a deferred underwriting discount of 3.5% of the gross proceeds of the Public Offering and Over-allotment Option (“Deferred Commissions”) at the time of the closing of the Business Combination. The Deferred Commission was placed in the Trust Account at the completion of the Public Offering and will be forfeited if the Company is unable to complete a Business Combination in the prescribed time. Registration Rights Holders of the Founder Shares, the Private Placement Warrants, and warrants that may be issued on conversion of working capital loans (and any Class A Shares issuable upon exercise of such warrants and upon conversion of the Founder Shares) will be entitled to registration rights with respect to such securities (in the case of the Founder Shares, only after conversion to Class A Shares) pursuant to an agreement signed on the effective date of the Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities for resale. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Business Combination. However, the registration rights agreement will provide that the Company will not permit any registration statement to become effective until termination of applicable lock-up periods with respect to such securities.

XML 21 R10.htm IDEA: XBRL DOCUMENT

Cash Held in Trust Account	3 Months Ended
Cash Held in Trust Account	Mar. 31, 2017
Cash Held in Trust Account
Cash Held in Trust Account	Note 5—Cash Held in Trust Account Gross proceeds of $310,000,000 and $8,200,000 from the Public Offering and Over-allotment Option, and Private Placement, respectively, less underwriting discounts of $6,200,000 and $2,000,000 designated for offering expenses and to fund the Company’s ongoing administrative and acquisition search costs, were held in the Trust Account at the close date. On January 6, 2017, funds held in the Trust Account were invested in US Treasury Bills, which are considered Level 1 investments under ASC 820. For the three months ended March 31, 2017, the investments held in the Trust Account generated interest income of $359,511. At March 31, 2017, the balance of funds held in the Trust Account was $310,359,511.

- Definition

The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.

+ References + Details

XML 22 R11.htm IDEA: XBRL DOCUMENT

Related Party Transactions	3 Months Ended
Related Party Transactions	Mar. 31, 2017
Related Party Transactions
Related Party Transactions	Note 6—Related Party Transactions Related Party Loans The Company issued to the Sponsor on December 14, 2015, as amended and restated on September 1, 2016, an unsecured promissory note pursuant to which the Company was permitted to borrow up to $300,000 in aggregate principal amount. Between inception and the Close Date, the Company borrowed $300,000. This note was non-interest bearing and was repaid in full to the Sponsor at the Close Date. The Sponsor may make a working capital loan to the Company and up to $1,500,000 of such loan may be converted into warrants, at the price of $0.50 per warrant at the option of the Sponsor. Such warrants would be identical to the Private Placement Warrants. Administrative Services Agreement The Company presently occupies office space provided by an Affiliate. The Affiliate has agreed that, until the Company consummates a Business Combination, it will make such office space, as well as certain support services, available to the Company, as may be required by the Company from time to time. The Company will pay the Affiliate an aggregate of $10,000 per month for such office space and support services. As of April 30, 2017, the Affiliate has agreed to defer payment of the monthly administrative fee under the Administrative Services Agreement until the initial Business Combination, at which time all such accrued but unpaid fees will be paid to the Affiliate. Private Placement Warrants The Initial Shareholders purchased 16,000,000 Private Placement Warrants at $0.50 per warrant (for an aggregate purchase price of $8,000,000) from the Company in a Private Placement on the Close Date. A portion of the proceeds from the sale of the Private Placement Warrants were placed into the Trust Account. The Initial Shareholders have also purchased an additional 400,000 Private Placement Warrants at $0.50 per warrant (for an aggregate purchase price of $200,000) simultaneously with the underwriter’s exercise of the Over-Allotment Option. Each Private Placement Warrant is exercisable for one-half of one Class A Share. Two Private Placement Warrants must be exercised for one whole Class A Share at a price of $11.50 per share. The Private Placement Warrants are identical to the Warrants included in the Units to be sold in the Public Offering except that the Private Placement Warrants: (i) will not be redeemable by the Company and (ii) may be exercised for cash or on a cashless basis, as described in the registration statement relating to the Public Offering, so long as they are held by the Initial Shareholders or any of their permitted transferees. Additionally, the Initial Shareholders have agreed not to transfer, assign or sell any of the Private Placement Warrants, including the Class A Shares issuable upon exercise of the Private Placement Warrants (except to certain permitted transferees), until 30 days after the completion of the Business Combination. Founder Shares In connection with the organization of the Company, on December 14, 2015, an aggregate of 8,625,000 Class B Shares (the “Founder Shares”) were sold to the Sponsor at a price of approximately $0.003 per share, for an aggregate price of $25,000. In October 2016, the Sponsor transferred 50,000 Founder Shares to each of the Company’s independent directors at a price per share of approximately $0.003 per share. In addition, at such time, each of our independent directors purchased an additional 421,250 Founder Shares from our Sponsor at a price per share of approximately $0.003 per share. The 8,625,000 Founder Shares included an aggregate of up to 1,125,000 shares that were subject to forfeiture if the Over-allotment Option was not exercised in full by the Underwriters in order to maintain the Initial Shareholders’ ownership at 20% of the issued and outstanding Ordinary Shares upon completion of the Public Offering. Following the partial exercise of the Over-allotment Option, 875,000 Founder Shares were forfeited in order to maintain the Initial Shareholder’s ownership at 20% of the issued and outstanding Ordinary shares. The Founder Shares are identical to the Class A Shares included in the Units sold in the Public Offering, except that the Founder Shares (i) have the voting rights described in Note 7, (ii) are subject to certain transfer restrictions described below, and (iii) are convertible into Class A Shares on a one-for-one basis, subject to adjustment pursuant to the anti-dilution provisions contained therein. The Founder Shares may not be transferred, assigned or sold until the earlier of (i) one year after the completion of the Business Combination and (ii) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction after the Business Combination that results in all of the Public Shareholders having the right to exchange their Class A Shares for cash, securities or other property. Notwithstanding the foregoing, if the last sale price of the Class A Shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 trading day period commencing at least 150 days after the Business Combination, the Founder Shares will be released from the lock-up.

XML 23 R12.htm IDEA: XBRL DOCUMENT

Shareholders' Equity	3 Months Ended
Shareholders' Equity	Mar. 31, 2017
Shareholders' Equity
Shareholders' Equity	Note 7—Shareholders’ Equity Preferred Shares The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.0001. The Company’s board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. The board of directors will be able to, without shareholder approval, issue preferred shares with voting and other rights that could adversely affect the voting power and other rights of the holders of the Ordinary Shares and could have anti-takeover effects. At March 31, 2017 there were no preferred shares issued or outstanding. Ordinary Shares The Company is authorized to issue 200,000,000 Class A Shares, with a par value of $0.0001 each, and 20,000,000 Class B ordinary shares, with a par value of $0.0001 each (the “Class B Shares” and, together with the Class A Shares, the “Ordinary Shares”). Holders of the Ordinary Shares are entitled to one vote for each Ordinary Share; provided, that only holders of the Class B Shares have the right to vote on the election of directors prior to the Business Combination. The Class B Shares will automatically convert into Class A Shares at the time of the Business Combination, on a one-for-one basis, subject to adjustment for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A Shares, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Public Offering and related to the closing of the Business Combination, the ratio at which the Class B Shares shall convert into Class A Shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of Class A Shares issuable upon conversion of all Class B Shares will equal, in the aggregate, 20% of the sum of all Ordinary Shares outstanding upon completion of the Public Offering plus all Class A Shares and equity-linked securities issued or deemed issued in connection with the Business Combination, excluding any Ordinary Shares or equity-linked securities issued, or to be issued, to any seller in the Business Combination. Holders of Founder Shares may also elect to convert their Class B Shares into an equal number of Class A Shares, subject to adjustment as provided above, at any time. At March 31, 2017 there were 31,000,000 Class A Shares issued and outstanding, of which 29,490,640 shares were subject to possible redemption and are classified outside of shareholders’ equity at the balance sheet date and 7,750,000 Class B Shares issued and outstanding. Redeemable Ordinary Shares The Class A Shares subject to possible redemption will be recorded at redemption value and classified as temporary equity in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 480, Distinguishing Liabilities from Equity. The Company will proceed with a Business Combination only if it has net tangible assets of at least $5,000,001 upon consummation of the Business Combination and, in the case of a shareholder vote, a majority of the outstanding Ordinary Shares voted are voted in favor of the Business Combination. Accordingly, at March 31, 2017, 29,490,640 of the Company’s 31,000,000 Class A Shares were classified outside of permanent equity at their redemption value.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74567-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

+ Details

XML 24 R13.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Policies)	3 Months Ended
Significant Accounting Policies (Policies)	Mar. 31, 2017
Significant Accounting Policies
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in U.S dollars in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with US GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all of the information and footnotes necessary for a comprehensive presentation of the financial position, results of operations or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s final prospectus as filed with the SEC on October 10, 2016 and declared effective on October 7, 2016, as well as the Company’s form 8-K, as filed with the SEC on October 20, 2016. Operating results for the three months ended March 31, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017 or any other future period.
Emerging Growth Company	Emerging Growth Company Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
Use of Estimates	Use of Estimates The preparation of the Company’s financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Financial Instruments	Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, Fair Value Measurements and Disclosures, approximates the carrying amounts represented in the balance sheet.
Fair Value Measurement	Fair Value Measurement ASC 820 establishes a fair value hierarchy that prioritizes and ranks the level of observability of inputs used to measure investments at fair value. The observability of inputs is impacted by a number of factors, including the type of investment, characteristics specific to the investment, market conditions and other factors. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level I measurements) and the lowest priority to unobservable inputs (Level III measurements). Investments with readily available quoted prices or for which fair value can be measured from quoted prices in active markets will typically have a higher degree of input observability and a lesser degree of judgment applied in determining fair value. The three levels of the fair value hierarchy under ASC 820 are as follows: Level I — Quoted prices (unadjusted) in active markets for identical investments at the measurement date are used. Level II — Pricing inputs are other than quoted prices included within Level I that are observable for the investment, either directly or indirectly. Level II pricing inputs include quoted prices for similar investments in active markets, quoted prices for identical or similar investments in markets that are not active, inputs other than quoted prices that are observable for the investment, and inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level III — Pricing inputs are unobservable and include situations where there is little, if any, market activity for the investment. The inputs used in determination of fair value require significant judgment and estimation. In some cases, the inputs used to measure fair value might fall within different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the investment is categorized in its entirety is determined based on the lowest level input that is significant to the investment. Assessing the significance of a particular input to the valuation of an investment in its entirety requires judgment and considers factors specific to the investment. The categorization of an investment within the hierarchy is based upon the pricing transparency of the investment and does not necessarily correspond to the perceived risk of that investment.
Offering Costs	Offering Costs The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A; “Expenses of Offering”. The Company incurred offering costs in connection with its Public Offering of $833,589, primarily consisting of accounting and legal services, securities registration expenses and exchange listing fees, and excluding $6,200,000 in underwriting discounts and $10,850,000 in deferred underwriting discounts. These offering costs, along with underwriting discounts, were charged to shareholders’ equity.
Net Income Per Share	Net Income Per Share Net income/(loss) per ordinary share is computed by dividing net income attributable to ordinary shares by the weighted average number of ordinary shares outstanding during the period (excluding 29,490,640 Class A Shares subject to possible redemption as of March 31, 2017 and 1,125,000 Class B Shares subject to forfeiture as of March 31, 2016), plus, to the extent dilutive, the incremental number of Class A Shares to settle the Private Placement Warrants and the Warrants included in the Units. At March 31, 2017, the Company had outstanding warrants for the purchase of up to 23,700,000 Class A Shares. For the period ended March 31, 2017, the weighted average of these shares was excluded from the calculation of diluted net income per ordinary share since the exercise of the warrants is contingent on the occurance of future events. As a result, diluted net income per ordinary share is equal to basic net income/(loss) per ordinary share.
Income Taxes	Income Taxes The Company accounts for income taxes under FASB ASC 740, Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits as of March 31, 2017. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying balance sheet.
Subsequent Events	Subsequent Events On April 6, 2017, the Company invested the funds held in the Trust Account in U.S. Treasury Bills maturing on July 6, 2017. Other than the foregoing, management has performed an evaluation of subsequent events from March 31, 2017 through the date which these financial statements were issued. Based upon the review, management did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements.

XML 25 R14.htm IDEA: XBRL DOCUMENT

Organization and Plan of Business Operations - Organization and General (Details) - USD ($)			3 Months Ended
	Nov. 28, 2016	Oct. 14, 2016	Mar. 31, 2017	Dec. 31, 2016
Organization and Financing
Par value of common stock (in dollars per share)			$ 0.0001	$ 0.0001
Revenue			$ 0
Class A
Organization and Financing
Par value of common stock (in dollars per share)			$ 0.0001	0.0001
IPO
Organization and Financing
Sale of units		310,000,000	30,000,000
Price of units (in dollars per unit)		$ 10.00	$ 10.00
Number of warrants included in each unit		1	1
IPO \| Class A
Organization and Financing
Number of shares of common stock included in each unit		1	1
Par value of common stock (in dollars per share)			$ 0.0001	$ 0.0001
Number of shares called by each warrant		0.5	0.5
Over-Allotment Option
Organization and Financing
Sale of units	1,000,000
Term of option to purchase additional units			45 days
Over-Allotment Option \| Maximum
Organization and Financing
Additional units available for purchase			4,500,000

XML 26 R15.htm IDEA: XBRL DOCUMENT

Organization and Plan of Business Operations - Financing (Details) - USD ($)			3 Months Ended
	Nov. 28, 2016	Oct. 14, 2016	Mar. 31, 2017
Private Placement
Organization and Financing
Warrants issued (in shares)	400,000	16,000,000
Purchase price of warrants		$ 0.50
Aggregate value of warrants, net of proceeds reserved for operations		$ 8,000,000
Aggregate value of warrants		8,200,000
IPO
Organization and Financing
Net proceeds from sale of units		310,000,000
Payment of underwriting discounts		6,200,000
Funds designated for operational use		$ 2,000,000
Sale of units		310,000,000	30,000,000
Over-Allotment Option
Organization and Financing
Sale of units	1,000,000
Over-Allotment Option and Private Placement
Organization and Financing
Payment of underwriting discounts	$ 200,000
Over-Allotment Option and Private Placement \| Assets held in trust
Organization and Financing
Net proceeds from sale of units	$ 10,000,000

XML 27 R16.htm IDEA: XBRL DOCUMENT

Organization and Plan of Business Operations - The Trust Account (Details)	Mar. 31, 2017 USD ($)
The Trust Account
Accrued interest receivable held in trust account	$ 359,511
U.S. Treasury bills \| Fair Value, Inputs, Level 1
The Trust Account
Cash balance in the Trust Account	$ 310,359,511

XML 28 R17.htm IDEA: XBRL DOCUMENT

Organization and Plan of Business Operations - Business Combination and Liquidity (Details)	3 Months Ended
	Mar. 31, 2017 USD ($) item $ / shares
Business Combination
Business combination, redemption valuation period prior to consummation	2 days
Uncompleted business combination, wind-up period	10 days
Liquidity
Cash held outside of the Trust Account available for working capital	$ 345,377
Minimum
Business Combination
Number of target businesses for Business Combination \| item	1
Class A \| Maximum
Business Combination
Percent of aggregate public shares that may be redeemed by a shareholder	15.00%
Assets held in trust
Business Combination
Price of units (in dollars per unit) \| $ / shares	$ 10.00
Assets held in trust \| Maximum
Business Combination
Portion of interest income allowed to pay dissolution expenses	$ 50,000
Assets held in trust \| Minimum
Business Combination
Business combination, fair value percent of assets held in trust	80.00%

XML 29 R18.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Details) - USD ($)		3 Months Ended
Significant Accounting Policies (Details) - USD ($)	Oct. 14, 2016	Mar. 31, 2017	Mar. 31, 2016
Concentration of Credit Risk
Federal depository insurance coverage		$ 250,000
Income Taxes
Unrecognized tax benefits		$ 0
Class A
Net Income Per Share
Ordinary shares subject to possible redemption, shares issued		29,490,640
Outstanding warrants to purchase Class A Shares		23,700,000
Class B
Net Income Per Share
Shares subject to forfeiture			1,125,000
IPO
Offering Costs
Offering Costs	$ 833,589
Underwriting discounts	6,200,000
Deferred underwriting commission	$ 10,850,000

XML 30 R19.htm IDEA: XBRL DOCUMENT

Public Offering (Details) - $ / shares			3 Months Ended
Public Offering (Details) - $ / shares	Nov. 28, 2016	Oct. 14, 2016	Mar. 31, 2017
Public Offering
Period after the completion of the Business Combination for exercise of warrants (in days)		30 days
Period from closing of Public Offering for exercise of warrants (in months)		12 months
Expiration period of warrants after completion of the Business Combination		5 years
Redemption price per warrant		$ 0.01
Redemption notice period		30 days
Warrants redemption covenant, threshold trading days		20 days
Warrants redemption covenant, threshold consecutive trading days		30 days
Class A
Public Offering
Number of warrants required for conversion to one whole share		2
Exercise price		$ 11.50
Minimum price per share required for redemption of warrants		$ 24.00
IPO
Public Offering
Sale of units		310,000,000	30,000,000
Price of units (in dollars per unit)		$ 10.00	$ 10.00
Number of warrants included in each unit		1	1
IPO \| Class A
Public Offering
Number of shares of common stock included in each unit		1	1
Number of shares called by each warrant		0.5	0.5
Over-Allotment Option
Public Offering
Sale of units	1,000,000
IPO and Over-Allotment Option
Public Offering
Sale of units		31,000,000

XML 31 R20.htm IDEA: XBRL DOCUMENT

Commitments (Details) - item	Mar. 31, 2017	Oct. 14, 2016
Registration Rights
Maximum number of demands	3
IPO
Underwriting Agreement
Underwriting discount		2.00%
Deferred underwriting discount	3.50%
Over-Allotment Option
Underwriting Agreement
Underwriting discount		2.00%
Deferred underwriting discount	3.50%

XML 32 R21.htm IDEA: XBRL DOCUMENT

Cash Held in Trust Account (Details) - USD ($)		3 Months Ended
Cash Held in Trust Account (Details) - USD ($)	Oct. 14, 2016	Mar. 31, 2017
Cash Held in Trust Account
Interest income		$ 359,511
U.S. Treasury bills \| Fair Value, Inputs, Level 1
Cash Held in Trust Account
Cash balance in the Trust Account		$ 310,359,511
IPO and Over-Allotment Option
Cash Held in Trust Account
Net proceeds from sale of units	$ 310,000,000
Private Placement
Cash Held in Trust Account
Proceeds from issuance of Private Placement Warrants	8,200,000
IPO
Cash Held in Trust Account
Net proceeds from sale of units	310,000,000
Underwriting discounts	6,200,000
Funds designated for operational use	$ 2,000,000

XML 33 R22.htm IDEA: XBRL DOCUMENT

Related Party Transactions - Related Party Loans and Administrative Services Agreement (Details) - USD ($)		10 Months Ended
	Oct. 14, 2016	Oct. 14, 2016	Mar. 31, 2017	Dec. 14, 2015
Related Party Loans \| Sponsor \| Unsecured Promissory Note
Related Party Transactions
Promissory note, maximum borrowing capacity				$ 300,000
Amount borrowed between inception and the Close Date		$ 300,000
Repayment of note payable to Sponsor	$ (300,000)
Related Party Loans \| Sponsor \| Working Capital Loan
Related Party Transactions
Conversion price per warrant			$ 0.50
Related Party Loans \| Sponsor \| Working Capital Loan \| Maximum
Related Party Transactions
Portion of working capital loan that may be converted into warrants			$ 1,500,000
Administrative Services Agreement
Related Party Transactions
Monthly payment for office space and support services			$ 10,000

XML 34 R23.htm IDEA: XBRL DOCUMENT

Related Party Transactions - Private Placement Warrants (Details) - USD ($)			3 Months Ended
	Nov. 28, 2016	Oct. 14, 2016	Mar. 31, 2017
Related Party Transactions
Period after the completion of the Business Combination for exercise of warrants (in days)		30 days
Private Placement
Related Party Transactions
Warrants issued (in shares)	400,000	16,000,000
Purchase price of warrants		$ 0.50
Aggregate value of warrants, net of proceeds reserved for operations		$ 8,000,000
Aggregate value of warrants		$ 8,200,000
Class A
Related Party Transactions
Number of warrants required for conversion to one whole share		2
Exercise price		$ 11.50
Private Placement Warrants
Related Party Transactions
Period after the completion of the Business Combination for exercise of warrants (in days)			30 days
Private Placement Warrants \| Private Placement
Related Party Transactions
Warrants issued (in shares)		16,000,000
Purchase price of warrants		$ 0.50
Aggregate value of warrants, net of proceeds reserved for operations		$ 8,000,000
Number of shares called by each warrant			0.5
Private Placement Warrants \| Class A
Related Party Transactions
Exercise price			$ 11.50
Private Placement Warrants \| Class A \| Private Placement
Related Party Transactions
Number of warrants required for conversion to one whole share			2
Private Placement Warrants \| Initial Shareholders \| Private Placement
Related Party Transactions
Warrants issued (in shares)	400,000
Purchase price of warrants	$ 0.50
Aggregate value of warrants	$ 200,000

XML 35 R24.htm IDEA: XBRL DOCUMENT

Related Party Transactions - Founder Shares (Details)			1 Months Ended	3 Months Ended
Related Party Transactions - Founder Shares (Details)	Oct. 14, 2016 shares	Dec. 14, 2015 USD ($) $ / shares shares	Oct. 31, 2016 $ / shares shares	Mar. 31, 2017 USD ($) $ / shares shares	Mar. 31, 2016 shares	Dec. 31, 2016 USD ($) shares
Related Party Transactions
Minimum ownership of ordinary shares by initial shareholders (as a percent)				20.00%
Founder Shares redemption covenant, minimum price per share \| $ / shares				$ 12.00
Class B
Related Party Transactions
Ordinary shares, shares issued				7,750,000		7,750,000
Ordinary shares, value \| $				$ 775		$ 775
Shares subject to forfeiture					1,125,000
Ratio of conversion from Class B to Class A ordinary shares				1
Founder Shares Transactions \| Class B
Related Party Transactions
Ratio of conversion from Class B to Class A ordinary shares				1
Restriction to transfer Class B ordinary shares (in years)				1 year
Founder Shares redemption covenant, threshold trading days				20 days
Founder Shares redemption covenant, threshold consecutive trading days				30 days
Founder Shares redemption covenant, minimum restriction term (in days)				150 days
Founder Shares Transactions \| Sponsor
Related Party Transactions
Shares subject to forfeiture		1,125,000
Founder Shares Transactions \| Sponsor \| Class B
Related Party Transactions
Ordinary shares, shares issued		8,625,000
Price per share \| $ / shares		$ 0.003
Ordinary shares, value \| $		$ 25,000
Shares forfeited	875,000
Founder Shares Transactions \| Initial Shareholders
Related Party Transactions
Minimum ownership of ordinary shares by initial shareholders (as a percent)	20.00%	20.00%
Founder Shares Transactions \| Director \| Class B
Related Party Transactions
Ordinary shares, shares issued			50,000
Price per share \| $ / shares			$ 0.003
Additional purchase of ordinary shares			421,250

XML 36 R25.htm IDEA: XBRL DOCUMENT

Shareholders' Equity (Details)	3 Months Ended
Shareholders' Equity (Details)	Mar. 31, 2017 USD ($) $ / shares shares	Dec. 31, 2016 $ / shares shares
Shareholders' Equity
Preferred shares, shares authorized	1,000,000	1,000,000
Preferred shares, par value (in dollar per share) \| $ / shares	$ 0.0001	$ 0.0001
Preferred shares, shares issued	0	0
Preferred shares, shares outstanding	0	0
Ordinary shares, shares authorized	220,000,000	220,000,000
Ordinary shares, par value (in dollar per share) \| $ / shares	$ 0.0001	$ 0.0001
Ordinary shares, voting rights per share	one vote
Minimum ownership of ordinary shares by initial shareholders (as a percent)	20.00%
Ordinary shares subject to redemption, shares issued	29,490,640	29,510,755
Ordinary shares subject to redemption, shares outstanding	29,490,640
Net tangible assets \| $	$ 5,000,001
Class A
Shareholders' Equity
Ordinary shares, shares authorized	200,000,000	200,000,000
Ordinary shares, par value (in dollar per share) \| $ / shares	$ 0.0001	$ 0.0001
Total ordinary shares issued, including shares subject to redemption	31,000,000
Total ordinary shares outstanding, including shares subject to redemption	31,000,000
Ordinary shares, shares issued	1,509,360	1,489,245
Ordinary shares, shares outstanding	1,509,360	1,489,245
Class B
Shareholders' Equity
Ordinary shares, shares authorized	20,000,000	20,000,000
Ordinary shares, par value (in dollar per share) \| $ / shares	$ 0.0001	$ 0.0001
Ratio of conversion from Class B to Class A ordinary shares	1
Ordinary shares, shares issued	7,750,000	7,750,000
Ordinary shares, shares outstanding	7,750,000	7,750,000

EXCEL 37 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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�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end XML 38 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 39 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 41 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 66 139 1 false 21 0 false 5 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.avistahealthcare.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - CONDENSED BALANCE SHEETS Sheet http://www.avistahealthcare.com/role/StatementCondensedBalanceSheets CONDENSED BALANCE SHEETS Statements 2 false false R3.htm 00105 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) Sheet http://www.avistahealthcare.com/role/StatementCondensedBalanceSheetsParenthetical CONDENSED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://www.avistahealthcare.com/role/StatementCondensedStatementsOfOperationsUnaudited CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) Statements 4 false false R5.htm 00300 - Statement - CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://www.avistahealthcare.com/role/StatementCondensedStatementsOfCashFlowsUnaudited CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 5 false false R6.htm 10101 - Disclosure - Organization and Plan of Business Operations Sheet http://www.avistahealthcare.com/role/DisclosureOrganizationAndPlanOfBusinessOperations Organization and Plan of Business Operations Notes 6 false false R7.htm 10201 - Disclosure - Significant Accounting Policies Sheet http://www.avistahealthcare.com/role/DisclosureSignificantAccountingPolicies Significant Accounting Policies Notes 7 false false R8.htm 10301 - Disclosure - Public Offering Sheet http://www.avistahealthcare.com/role/DisclosurePublicOffering Public Offering Notes 8 false false R9.htm 10401 - Disclosure - Commitments Sheet http://www.avistahealthcare.com/role/DisclosureCommitments Commitments Notes 9 false false R10.htm 10501 - Disclosure - Cash Held in Trust Account Sheet http://www.avistahealthcare.com/role/DisclosureCashHeldInTrustAccount Cash Held in Trust Account Notes 10 false false R11.htm 10601 - Disclosure - Related Party Transactions Sheet http://www.avistahealthcare.com/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 11 false false R12.htm 10701 - Disclosure - Shareholders' Equity Sheet http://www.avistahealthcare.com/role/DisclosureShareholdersEquity Shareholders' Equity Notes 12 false false R13.htm 20202 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.avistahealthcare.com/role/DisclosureSignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.avistahealthcare.com/role/DisclosureSignificantAccountingPolicies 13 false false R14.htm 40101 - Disclosure - Organization and Plan of Business Operations - Organization and General (Details) Sheet http://www.avistahealthcare.com/role/DisclosureOrganizationAndPlanOfBusinessOperationsOrganizationAndGeneralDetails Organization and Plan of Business Operations - Organization and General (Details) Details 14 false false R15.htm 40102 - Disclosure - Organization and Plan of Business Operations - Financing (Details) Sheet http://www.avistahealthcare.com/role/DisclosureOrganizationAndPlanOfBusinessOperationsFinancingDetails Organization and Plan of Business Operations - Financing (Details) Details 15 false false R16.htm 40103 - Disclosure - Organization and Plan of Business Operations - The Trust Account (Details) Sheet http://www.avistahealthcare.com/role/DisclosureOrganizationAndPlanOfBusinessOperationsTrustAccountDetails Organization and Plan of Business Operations - The Trust Account (Details) Details 16 false false R17.htm 40104 - Disclosure - Organization and Plan of Business Operations - Business Combination and Liquidity (Details) Sheet http://www.avistahealthcare.com/role/DisclosureOrganizationAndPlanOfBusinessOperationsBusinessCombinationAndLiquidityDetails Organization and Plan of Business Operations - Business Combination and Liquidity (Details) Details 17 false false R18.htm 40201 - Disclosure - Significant Accounting Policies (Details) Sheet http://www.avistahealthcare.com/role/DisclosureSignificantAccountingPoliciesDetails Significant Accounting Policies (Details) Details http://www.avistahealthcare.com/role/DisclosureSignificantAccountingPoliciesPolicies 18 false false R19.htm 40301 - Disclosure - Public Offering (Details) Sheet http://www.avistahealthcare.com/role/DisclosurePublicOfferingDetails Public Offering (Details) Details http://www.avistahealthcare.com/role/DisclosurePublicOffering 19 false false R20.htm 40401 - Disclosure - Commitments (Details) Sheet http://www.avistahealthcare.com/role/DisclosureCommitmentsDetails Commitments (Details) Details http://www.avistahealthcare.com/role/DisclosureCommitments 20 false false R21.htm 40501 - Disclosure - Cash Held in Trust Account (Details) Sheet http://www.avistahealthcare.com/role/DisclosureCashHeldInTrustAccountDetails Cash Held in Trust Account (Details) Details http://www.avistahealthcare.com/role/DisclosureCashHeldInTrustAccount 21 false false R22.htm 40601 - Disclosure - Related Party Transactions - Related Party Loans and Administrative Services Agreement (Details) Sheet http://www.avistahealthcare.com/role/DisclosureRelatedPartyTransactionsRelatedPartyLoansAndAdministrativeServicesAgreementDetails Related Party Transactions - Related Party Loans and Administrative Services Agreement (Details) Details 22 false false R23.htm 40602 - Disclosure - Related Party Transactions - Private Placement Warrants (Details) Sheet http://www.avistahealthcare.com/role/DisclosureRelatedPartyTransactionsPrivatePlacementWarrantsDetails Related Party Transactions - Private Placement Warrants (Details) Details 23 false false R24.htm 40603 - Disclosure - Related Party Transactions - Founder Shares (Details) Sheet http://www.avistahealthcare.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails Related Party Transactions - Founder Shares (Details) Details 24 false false R25.htm 40701 - Disclosure - Shareholders' Equity (Details) Sheet http://www.avistahealthcare.com/role/DisclosureShareholdersEquityDetails Shareholders' Equity (Details) Details http://www.avistahealthcare.com/role/DisclosureShareholdersEquity 25 false false All Reports Book All Reports ahpau-20170331.xml ahpau-20170331.xsd ahpau-20170331_cal.xml ahpau-20170331_def.xml ahpau-20170331_lab.xml ahpau-20170331_pre.xml true true ZIP 43 0001104659-17-032338-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-17-032338-xbrl.zip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